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ABSTRACT

The behavior of breast epithelial cells is influenced by their microenvironment,
which includes stromal cells and extracellular matrix. During breast cancer
progression, the tissue microenvironment fails to control proliferation, resulting in
uncontrolled growth and invasion. Upon invasion, the extracellular matrix
encountered by breast cancer cells changes from primarily laminin and collagen
IV to primarily collagen I. The current study used a three-dimensional (3D)
collagen I culture model to address how the microenvironment controls the
breast cancer cell cycle after invasion through the basement membrane. We
show that culturing breast cancer cells in 3D collagen I inhibits proliferation
through direct regulation of cyclin E1, a G 1 /S regulator that is overexpressed in
breast cancer and implicated in its etiology. When the breast cancer cell line
MDA-MB-231 was cultured within 3D collagen I gels, the G 1 /S transition was
inhibited as compared to cells cultured on conventional 2D collagen or plastic
dishes. Cells in 3D collagen downregulated cyclin E1 protein and mRNA, with no
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change in cyclin D1 level. Cyclin D1 regulates progression through early G 1 ,
where it is upregulated by signals from the extracellular environment. Cyclin D1
relocalized to the cytoplasm in 3D cultures and phosphorylation of Rb, a nuclear
target for both cyclin E1- and cyclin D1-associated kinases, was decreased.
Positive regulators of cyclin E1, the transcription factor c-Myc and cold-inducible
RNA binding protein (CIRP), were decreased in 3D collagen cultures, while the
collagen I receptor β 1 integrin was greatly increased. Inhibition of β 1 integrin
function rescued proliferation, cyclin E1 and c-Myc expression, and Rb
phosphorylation, but had no effect on cyclin D1 localization. We conclude that
cyclin E1 is repressed independent of effects on cyclin D1 in a 3D collagen
environment and dependent on β 1 integrin interaction with collagen I, reducing
proliferation of invasive breast cancer cells. These results differ from studies of
breast epithelial and cancer cells in 2D collagen or 3D Matrigel in which
disruption of β 1 integrin function decreased proliferation. We also show that
matrix metalloproteinases (MMPs) MMP-2 and MMP-9 increased dramatically in
3D collagen. Their inhibition reversed cyclin E1 reduction, indicating their
upregulation may be key to this process. In addition to studying MDA-MB-231
cells, we show that 3D collagen has similar effects on the nontumorigenic breast
epithelial cell line MCF10A and the breast cancer cell line HMT-3522 T4-2 cells.
Proliferation and cyclin E1 were downregulated in both of these cell lines, with
MCF10A cells undergoing global G 1 arrest and subsequent apoptosis. Our data
suggest that one way breast cancer cells adapt themselves to a collagen
environment is by upregulating a collagen I receptor to decrease proliferation
x

through cyclin E1 repression. Cyclin E1 therefore appears to link the ECM and
cell cycle machinery, arguing the importance of considering the role of ECM in
breast cancer etiology, valuing cyclin E1 as a prognostic factor, as well as
targeting cyclin E1 overexpression in clinical therapy.
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1.

INTRODUCTION

1.1. Cyclin E1 as a cell cycle regulator
1.1.1. Cyclins, cyclin-dependent kinases and the mammalian cell cycle

The mammalian cell cycle is controlled by a subfamily of cyclin-dependent
kinases (cdks) whose activity is regulated by several activators (cyclins) and cdk
inhibitors or CKIs (p16, p21, and p27). It has been over 26 years since cyclins
were originally described by Tim Hunt and his colleagues while observing mitotic
cleavage of sea urchin embryos (Evans et al., 1983). Cyclins were named based
on their dramatic cell cycle periodicity during meiotic and early mitotic divisions.
In a “classical” model of the mammalian cell cycle that has been broadly
accepted, cyclins, which bind to their catalytic partners, the cdks, are synthesized
and destroyed at certain times during the cell cycle thus regulating the kinase
activity in a timely manner (Fig.1.1, left). Cdk2, cdk3, cdk4 and cdk6 bind to their
specific cyclins to drive each of the main events during interphase; G 1 (Gap
phase 1), S (DNA Synthesis), and G 2 (Gap phase 2). Cdk1 binds to its cyclins to
drive mitosis. In human cells, 13 loci encoding cdks and 25 loci encoding cyclins
have been discovered so far (Malumbres and Barbacid, 2009). Although human
genome analysis has found that all the genes that encode cyclins share a
conserved stretch of 150 amino acid residues called the “cyclin box”, which is
formed by 5 helical regions, only 10 cyclins belonging to 4 different classes (the
A, B, D, and E-type cyclins) directly drive the cell cycle. Many other cyclins lack
known cdk or other kinase partners (Malumbres and Barbacid, 2005). Recently,
1

genetic evidence from mouse embryos with multiple knockouts has challenged
the above model by indicating that cdk1 is sufficient to drive the cell cycle while
interphase cdks are only important for specialized cell proliferation (Santamaria
et al., 2007). However, these observations do not suggest interphase cdks have
no contributions to normal cell cycles even in the cells in which they are
dispensable. Thus, in addition to the classical model of the mammalian cell
cycle, the “essential cell cycle model’’ and the “specialized cell cycle model” have
been proposed (Fig. 1.1) and emphasized how much there is still to learn about
the cell cycle (Malumbres and Barbacid, 2009; Murray, 2004). In this
dissertation, principles from the classical model are used.

1.1.2. Cyclin E1- one of the G1 cyclins
Mammalian G1 cyclins include D-type cyclins (D1, D2 and D3) that associate
with and activate cdk4 or cdk6 in early G1 (Sherr, 1995), and E-type cyclins (E1
and E2) that associate primarily with cdk2, but can also interact with cdk1 and
cdk3 (Aleem et al., 2005; Zariwala et al., 1998). Cyclin E2 shares 47% aminoacid homology with cyclin E1 and exhibits similar activities (Hwang and Clurman,
2005). Cyclin E1 is the best studied of the E-cyclins and will be the focus of this
dissertation. Cyclin E1 was first discovered by screening human cDNA libraries
for genes that could complement G1 cyclin mutations in Sacchromyces
cerevisiae (Lew et al., 1991). Its function in promoting the G1/S transition was
further confirmed when ectopic and constitutive expression of cyclin E1, but not
of cyclin D1 or cyclin A, led to accelerated G1 progression (Ohtsubo et al., 1995)
and chromosome instability (Spruck et al., 1999). Results from studies using
2

cyclin E-null mice suggested a function in endoreplication, exit from quiescence,
and oncogenic transformation (Geng et al., 2003; Parisi et al., 2003; Zhang,
2007). Cyclin E1 but not cyclin D1 is required for the G1/S transition in cells
lacking functional Rb and cyclin E1 can functionally replace cyclin D1 (Geng et
al., 1999). Other functions for cyclin E1 include centrosome duplication (Okuda
et al., 2000) and facilitating MCM (Mini-Chromosome Maintenance) complex
loading to chromatin for DNA replication (Geng et al., 2007). Besides its role as a
G1 cyclin, cyclin E1 can also function in mitosis and meiosis (Grimison et al.,
2006; Keck et al., 2007; Liu et al., 2007). Finally, cyclin E1 has been shown to
have an important function in genotoxic stress-induced apoptosis (Mazumder et
al., 2007). Originally identified as a regulator of the G1/S transition, cyclin E1 has
been found to have multiple functions and has become an attractive target in
cancer research. Understanding the regulation of cyclin E1 will help provide ways
to control cell cycle progression in cancer cells and limit their population of
distant metastatic sites.

1.2. Regulation of cyclin E1
Cyclin E1/cdk2 activity peaks at the G1/S transition and is lowest in cells
that are arrested in G0.This tight regulation during the normal cell cycle results
from multiple layers of control. These layers include regulation of cyclin E1
transcriptionally, post-transcriptionally, and post-translationally, as discussed
below.

1.2.1. Transcriptional regulation
3

The human cyclin E1 gene is on to chromosome 19q12, where it is
regulated by the transcription factor E2F. E2F binding sites are found in both
cyclin E1 and cyclin D1 promoters. For cyclin E1, the activity of its promoter is
affected by E2F in a cell-cycle dependent manner (Leone et al., 1999; Ohtani et
al., 1995). In early G1, hypophosphorylated Rb binds to E2F1 and inhibits its
activity. Cyclin D1 is induced by mitogenic stimulation in early G1 leading to
phosphorylation of Rb by cyclin D1/cdk4/cdk6 and release of E2F1. E2F1
recruits histone acetylases to the promoters of genes required for G1/S including
cyclin E1. Cyclin E1/cdk2 further phosphorylates Rb, reinforcing its own
expression (Matsumura et al., 2003). The transient induction of cyclin E1 in late
G1 is also controlled via a cyclin E1 repressor module (CERM), which has an
E2F-binding site and an AT-rich sequence that cooperate during G0/G1 to delay
cyclin E1 expression until late G1 (Le Cam et al., 1999; Polanowska et al., 2001).
In addition, viruses such as adenovirus E1A, human papillomavirus type 16, and
human cytomegalovirus have been found to transform cells by transcriptionally
activating cyclin E1 (Botz et al., 1996; Bresnahan et al., 1998; Vogt et al., 1999).
This subverts the cell cycle restriction point, which occurs before the G1/S phase
transition. The restriction point denotes the point in time when a cell must decide
to advance to S phase, to remain in G1, or to arrest into G0.
1.2.2. Post-transcriptional regulation
Nine alternatively spliced variants of cyclin E1 mRNA have been identified
to date. One, encoding a 45kDa isoform of cyclin E1, was originally considered
the full-length protein (Koff et al., 1991; Lew et al., 1991), but a 50kDa isoform is
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now known to be predominantly expressed (Ohtsubo et al., 1995). A 43kDa
splice variant expressed at 1/10 of the level of full length cyclin E1 is found in
several cell lines (Sewing et al., 1994). This isoform lacks the cyclin box
necessary for cdk2 activation. Of the other 6 splice variants, 4 can bind to and
activate cdk2 in vitro (the molecular weights of 3 of these are unknown), while
one splice variant and one unspliced variant are not translated into protein.
Cyclin E1 protein abundance is also determined via post-transcriptional
regulation of its mRNA stability. Two recent studies measured cyclin E1 mRNA
stability during the cell cycle using different cell lines and methods. In the first
study, human leukemic lymphocytes (MOLT-4) cells were grown on a surface
such that when a cell divided, one daughter cell remained attached while the
other was released into a collection flask. Newborn cells were collected, grown
synchronously, and the half-life of E1 mRNA was determined by real-time RTPCR. Cyclin E1 mRNA half-life was in the range of 1.5 to 2 h, with little
fluctuation in stability during different cell cycle phases (Eward et al., 2004). The
second study reported the same half-life using mouse EL4 lymphoma cells and
3T3 fibroblasts synchronized by elutriation or cell sorting (Penelova et al., 2005).
The intracellular half-lives of RNAs are determined by many factors,
including their affinity for RNA binding proteins (RBPs). HuR (Human antigen R)
is an RBP shown to stabilize mRNAs encoding cyclins A, B, D, and E, among
others. HuR is a predominantly nuclear protein but shuttles between the nucleus
and the cytoplasm, positively affecting mRNA stability and translation in the
cytoplasm (Bevilacqua et al., 2003). It plays an essential role in tumorigenesis by
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stabilizing transcripts involved in cell cycle regulation, such as cyclins (Wang et
al., 2000); proliferation such as c-Myc (Kim et al., 2009); tumor growth such as
vascular endothelial growth factor, cyclooxygenase-2, and β-catenin (Dixon et al.,
2001; Levy et al., 1998; Lopez de Silanes et al., 2003); anti-apoptotic effectors
such as Bcl-2 and Mcl-2 (Abdelmohsen et al., 2007); and metastasis, possibly
through vascular endothelial growth factor-C (Wang et al., 2009b). Cytoplasmic
expression of HuR is considered a prognostic factor in breast cancer, where it is
overepxressed in about 30% of tumors (Heinonen et al., 2005). Our laboratory
has shown that HuR contributes to cyclin E1 overexpression by stabilizing its
mRNA in MCF-7 breast cancer cells (Guo and Hartley, 2006). Cold-inducible
RBP (CIRP) also stabilizes cyclin E1 mRNA in breast cancer cells. CIRP is
overexpressed in several breast cancer cell lines (Guo et al., 2009) as well as in
about 30% of primary breast tumors (Artero-Castro et al., 2009). We found that
CIRP increased cyclin E1 mRNA stability partially by facilitating the binding of
HuR to cyclin E1 mRNA.
The translational efficiency of cyclin E1 mRNA was recently shown to be
promoted by the protein kinase Akt in hepatocytes (Mullany et al., 2007). This
novel translational mechanism is distinct from the cyclin D1-E2F transcriptional
pathway. This study suggested that cells can respond to environmental
stimulation (such as mitogens or nutrients) by direct stimulation of cyclin E1
translation by Akt to affect cell cycle progression.

6

1.2.3. Post-translational regulation
The abundance of cyclin E1 is also regulated by phosphorylationdependent proteolysis after the cyclin E1/cdk2 complex is activated at the G1/S
boundary. Cyclin E1 turnover is achieved by the ubiquitin-proteasome pathway.
Proteins targeted by this pathway require modification by successive actions of
ubiquitin-activating (E1) and -conjugating (E2) enzymes, and ubiquitin ligases
(E3), which attach polyubiquitin chains to specific lysine residues (Hao et al.,
2007). Polyubiquitinated proteins are then targeted and degraded by the 26S
proteasome into small peptides. Two pathways for ubiquitin-dependent
proteolysis of cyclin E1 have been reported. When cyclin E1 is not associated
with cdk2, Cullin-3 (Cul-3) promotes ubiquitination of cyclin E1 (Singer et al.,
1999; Wimuttisuk and Singer, 2007). Cul-3 belongs to the Cullin family proteins
that comprise the core module of the BTB/Cul3/Rbx1 ubiquitin ligase. When
cyclin E1 is bound to cdk2, it is protected from the Cul-3 mediated pathway and
multiple phosphorylations are required for its ubiquitination (Welcker et al.,
2003). Both cdk2 and glycogen synthase kinase-3β (GSK3β) phosphorylate
cyclin E1 on at least 4 different sites. Phosphorylated cyclin E1 is recognized by
Fbw7 (hCdc4), the substrate recognition subunit in the Skp1/Cul-1/F-box E3
ligase. There are Cdc4 isoforms required in cyclin E1 ubiquitination (Welcker et
al., 2004). The prolyl isomerase Pin1 regulates cyclin E1 turnover, dependent on
phosphorylation of cyclin E1 by cdk2 (Yeh et al., 2006). In addition to Cul-1 and
Cul-3 as described above, Cul-4B was recently reported to have an essential role
in cyclin E1 degradation (Zou et al., 2009).
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Another important post-translational modification of cyclin E1 is
processing of the full length protein into low molecular weight (LMW) isoforms.
These LMW isoforms (ranging from 33-45kDa) have been found in breast,
ovarian, gastric, colorectal, and lung cancers, and melanoma (Bales et al., 2005;
Bedrosian et al., 2004; Corin et al., 2006; Davidson et al., 2007; Koutsami et al.,
2006; Milne et al., 2008; Porter et al., 2001). They have an increased affinity for
cdk2, are resistant to cdk inhibitors, and their presence strongly correlates with
increasing stage and grade of breast cancer (Wingate et al., 2005a). Transgenic
mice expressing LMW cyclin E1 isoforms are susceptible to metastatic mammary
carcinoma while full-length cyclin E1 overexpressing mice are not, showing their
oncogenic potential. The origin of LMW cyclin E1 isoforms is still under debate.
Both alternative splicing (Porter and Keyomarsi, 2000b) and intracellular
proteolytic processing (Libertini et al., 2005; Porter et al., 2001; Wang et al.,
2003) have been implicated in their production. The LMW cyclin E1 isoforms are
thought to be cancer specific (Wingate et al., 2005b), but some studies show that
the ability to detect LMW cyclin E1 isoforms correlates only with the level of full
length cyclin E1 and they can be detected in both breast cancer and normal
mammary epithelial (ME) cells if full length cyclin E1 levels are normalized
(Spruck et al., 2006). A better understanding of how LMW isoforms are produced
is needed.
1.3. Deregulation of cyclin E1 in cancer
As one of the regulators involved in passing through the restriction point and
entry into S phase, cyclin E1 has been extensively studied in human cancers. A
8

number of cancers overexpress cyclin E1 protein or mRNA, including carcinomas
(e.g. of the breast, cervix, endometrium, gastrointestinal tract, and lung),
lymphomas, adrenocortical tumors, sarcomas and leukemias (Erlanson and
Landberg, 2001; Iida et al., 1997; Molendini et al., 1998; Muller-Tidow et al.,
2001; Schraml et al., 2003; Tissier et al., 2004; Yasui et al., 1996).
Overexpression of cyclin E1 results in chromosome instability, implicating it in
cancer etiology (Spruck et al., 1999).
Several mechanisms contribute to cyclin E1 deregulation in cancer including
transcriptional upregulation, disruption of its degradation, downregulation of cdk
inhibitors, mRNA stabilization, and processing into LMW isoforms, as described
in the previous section (Akli and Keyomarsi, 2004; Guo and Hartley, 2006; Guo
et al., 2009; Sutherland and Musgrove, 2004). Rb is inactivated in many human
cancers, resulting in increased cyclin E1 abundance transcriptionally through
increased E2F activity (Burkhart and Sage, 2008). In addition, transcriptional
regulator LIM-only protein 4 has also been shown to transcriptionally upregulate
cyclin E1 in breast cancer (Montanez-Wiscovich et al., 2009).
Disruption of cyclin E1 degradation also contributes to cancer etiology. It has
been shown that mutation of hCdc4 is sufficient to deregulate cyclin E1 in the
cancer cell cycle (Ekholm-Reed et al., 2004) and hCdc4 has been evaluated as a
general tumor suppressor that is inactivated by mutation in various human
cancers with an overall mutation frequency of 6% (Akhoondi et al., 2007). Ras
activity has been shown to regulate hCdc4-mediated cyclin E proteolysis, and
impaired cyclin E degradation as a mechanism through which Ras mutations
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promote tumorigenesis (Minella et al., 2005). Interestingly, overexpression of
E2F stabilizes cyclin E1 protein by reducing its ubiquitination thereby reducing its
degradation. This E2F action on cyclin E1 requires E2F transcriptional activity
and is specific for cyclin E1, indicating another possible mechanism for
increasing cyclin E1 accumulation in proliferating tumor cells (Pajalunga and
Crescenzi, 2004).
Downregulation of cdk inhibitors is often seen in cancer. In primary human
fibroblasts, deregulated cyclin E1 initiates a p53-dependent response that
induces cdk inhibitor p21 expression, preventing excess cyclin E1/cdk2 activity.
The response to restrain cyclin E1/cdk2 deregulation by both p53 and p21 is
proposed to be a general protective barrier against neoplastic transformation
(Minella et al., 2002). p27 is another cdk inhibitor that prevents premature
activation of cyclin E/cdk2 in G1. Although the p27 gene is rarely mutated in
human cancers, accelerated p27 proteolysis and its mislocalization from the
nucleus to the cytoplasm are often observed in tumor cells. P27 mislocalization
was reported in 40% of primary breast cancers (Blain and Massague, 2002).
Cytoplasmic localization of p27 prevents it from binding and inhibiting nuclear
targets such as cyclin E1/cdk2.
As discussed in section 1.2.2, cyclin E1 mRNA is regulated by the RBPs
HuR and CIRP, both of which are overexpressed in many human tumors. In
addition to RBPs, a class of small noncoding RNAs, termed microRNAs,
deregulate cyclin E1 in cancer cells. MicroRNAs inhibit gene expression by
binding to recognition elements, mainly in the 3' untranslated region of mRNA,
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resulting in mRNA destablization or translational inhibition (Iorio and Croce,
2009). miR-16 downregulates cyclin E1 by destabilizing its mRNA (Kaddar et al.,
2009). miR-16 is downregulated in several cancers (Bottoni et al., 2005; Calin et
al., 2002) and has been shown to induce G0/G1 cell cycle arrest partially through
downregulation of cyclin E1 in human lung and breast cancer cells (Wang et al.,
2009a).
1.4. Regulation of cyclin E1 by the cellular microenvironment
1.4.1. Definition, components and function of the cellular

microenvironment
The structure and function of normal tissues is largely determined by the
interactions between cells within tissue and their microenvironment

(Radisky et

al., 2002). This communication is so important that loss of tissue architecture
becomes a prerequisite for, and one of the critical characteristics of, most
cancers. On the other hand, a normal microenvironment that maintains organ
structure can act as a strong tumor suppressor, preventing or reversing
malignant phenotypes even in cells bearing genomic abnormalities. The cellular
microenvironment is defined as local and systemic constituents surrounding a
cell, including extracellular matrix (ECM), other cells, and soluble factors
released locally or transmitted from other organs, such as hormones, growth
factors, and cytokines (Nelson and Bissell, 2006). The ECM, to which the soluble
factors can bind, is a three-dimensional (3D) insoluble protein network. There are
two major categories of ECM including the basement membrane (BM) and the
interstitial matrix. The BM is primarily composed of type IV collagen, laminins,
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entactin/nidogen and heparin sulfate proteoglycans. Epithelial and endothelial
cells are directly surrounded by the BM, and that surrounding the BM is the
interstitial matrix. The interstitial matrix consists of many types of collagens, with
type I collagen being the most abundant component, along with elastic fibers,
fibronectin, tenascin and proteoglycans. This matrix provides the mechanical
strength, hydration, integrity and binding of soluble factors. Originally considered
only as a support system, the ECM is now recognized as a central regulator of
cell behavior including adhesion, migration, proliferation, differentiation, and
survival, by serving as a structural scaffold and an instructive environment (Erler
and Weaver, 2009).
1.4.2. Communication between the microenvironment and the cell cycle
Microenvironmental control of the cell cycle has been studied for more
than 40 years and led to the concept of anchorage-dependent cell growth
(Stoker et al., 1968). It is thought that integrin-mediated cell anchorage to the
ECM and growth factors cooperate to regulate cell cycle progression (Fig. 1.2).
Expressed by virtually all animal cells, integrins are the most abundant class of
ECM protein receptors. Integrins bind to ECM proteins and in some cases, to
membrane proteins expressed on the surface of other cells. They are signalling
receptors that control both cell binding to ECM and intracellular responses
following adhesion (Hehlgans et al., 2007).
Anchorage-dependent regulation controls two different periods of the cell
cycle. The first and also the primary control is during the G1 phase, when the
extracellular environment regulates cell cycle progression primarily via regulation
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of cyclin D1. Mitogenic growth factors and cell anchorage converge on the
signalling pathways that result in cyclin D1/cdk4/6 activity, promoting G1 phase
progression (Bohmer et al., 1996). Adhesion to substratum regulates both cyclin
D1 transcription and translation. Nonadherent cells fail to phosphorylate Rb,
while enforced expression of cyclin D1 rescues Rb phosphorylation and entry
into S phase in nonadherent G1 cells (Zhu et al., 1996). Cyclin E1 expression is
also responsive to extracellular signals. Anchorage-dependent control occurs in
Rb/p107 double-null mouse embryonic fibroblasts independent of cyclin D1 but
dependent on cyclin E1-associated kinase activity (Gad et al., 2004). Consistent
with this study, cyclin E1 and cyclin E1/cdk2 activity were up-regulated
independently of cyclin D1 in ME cells adhered to type I collagen (Klekotka et al.,
2001b).
Anchorage-dependent control also functions during cytokinesis.
Multinucleation and inhibition of cytokinesis were observed in suspended cells,
and attachment to proper substratum such as collagen I gel or a thin layer of
gelatin, was required in Xenopus embryos for cytokinesis, indicating that cell
anchorage may be important in this process (Ben-Ze'ev and Raz, 1981;
Winklbauer, 1986). Although non-adhered cells fail to complete cytokinesis,
anchorage-independent cytokinesis can be achieved through oncogenic
signalling (Thullberg et al., 2007). The role of cyclins has not been addressed
except that cyclin B1 localization in G2 and early M phase was studied but was
not changed in suspended as compared to attached cells. From these studies, it
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is clear that microenvironmental controls are necessary for the normal cell cycle
and that these controls are often disrupted in cancer.
1.4.3. Microenvironmental influences in the normal mammary gland
The mammary gland is the best-studied example of an organ whose
structure and function are influenced by reciprocal signalling and communication
between cells and their microenvironment. The influences are not only from local
constituent tissues, but also from distant organs (Fig. 1.3). The basic mammary
structure is a highly organized branched ductal network where milk is produced
by a continuous layer of luminal epithelial cells and secreted into a central lumen.
The luminal epithelial cells are surrounded by a layer of myoepithelial cells and
the double-layered structure is enclosed by the BM. The epithelial ductal tree is
embedded in a complex interstitial matrix including non-epithelial cells such as
fibroblasts, adipocytes, and capillaries. Although the mammary epithelium
(anlage) is specified in the embryo, the mammary gland is one of the few organs
that develops and matures postnatally during puberty. At puberty, the breast
initiates expansion at the ends of the ducts known as terminal end buds (TEBs).
The mammary gland reaches its fully functional differentiation during pregnancy
and lactation resulting in the formation of luminal structures that collect milk
produced by alveoli. The entire gland undergoes involution after weaning, during
which ME cells apoptose and are replaced by mesenchymal and adipose tissue,
to return the gland to its dormant state (Bissell et al., 2002).
Hormones, growth factors, cytokines, morphogens, ECM molecules,
proteases, physical stress and strain all play important roles in the development
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and remodeling of the mammary gland. Estrogen from the ovary and growth
hormone from the pituitary regulate the development of the mammary gland at
puberty. Progesterone and prolactin are also necessary for the ductal side
branching and alveoli development during pregnancy and lactation. Although
these systemic hormones are powerful regulators, their effects are not due to
direct action but rather through synergistic actions with multiple secondary
paracrine effectors that alter expression of transcription factors. Locally,
mammary gland branching is controlled by signals from both epithelial cells and
their surrounding stroma (Sakakura et al., 1976). Several estrogen receptor (ER)
knockout studies have shown the importance of the paracrine signalling events
that regulate ME cell proliferation and morphogenesis (Cunha et al., 1997;
Mallepell et al., 2006; Mueller et al., 2002). ERα is only expressed in a subset of
ME cells and ER positive cells release paracrine factors to control the
proliferation of adjacent ER-negative cells (Clarke et al., 1997). Growth hormone
is also thought to regulate the development of the mammary gland through a
stromal insulin-like growth factor 1 (Kleinberg et al., 2009). During the
proliferation of the mammary TEB, local influences from matrix
metalloproteinases (MMPs), cadherins, type I collagen and other ECM
components integrate with systemic hormones to regulate the whole process
(Hinck and Silberstein, 2005). Understanding these microenvironmental
influences are important for understanding breast cancer etiology as many
common mechanisms and signalling pathways have been observed in both
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mammary gland development and carcinogenesis (Lanigan et al., 2007; Noel
and Foidart, 1998).

1.5. Cellular microenvironment and breast cancer etiology
1.5.1. Using three-dimensional (3D) models to study breast cancer
More than 90% of human breast cancers arise from the ductal epithelium.
Numerous models have been developed to study the normal and neoplastic
mammary gland, including the cleared fat pad transplantation system (Deome et
al., 1959; Evers et al.) and transgenic mouse models, which have provided
significant insight into the genes and signalling pathways regulating normal and
aberrant cell behaviors (Muller, 1991; Radisky and Hartmann, 2009). These
models are relatively intractable for studying biochemical processes involved in
tumor formation. For studying the precise biochemical pathways controlling the
normal and malignant states in ME cells, cell culture-based studies are much
more amenable to manipulation. However, the mammary gland is not a 2dimensional (2D) structure. 2D monolayer cell culture systems cannot
recapitulate the structural organization and functional differentiation of the
mammary gland in vivo. Therefore, 3D culture systems have emerged as
tractable models that allow ME cells to organize and mimic their in vivo structure
and allow investigation of the cancer cell behaviors in a biologically relevant
context.
When culturing a single cell type in 3D, two different methods are typically
used. The first is to completely embed cells within a gelled ECM and culture with
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media containing growth factors and hormones. The second is to make a thin
ECM gel (~ 1mm), seed single cells on top, and overlay with media containing
diluted ECM components. Both systems have been successfully used to induce
acini formation [Fig. 1.4; (Hebner et al., 2008)]. Matrices such as Matrigel,
collagen I, fibrin and polyacrylamide gels have been utilized and their pros and
cons have been summarized in a recent review [Fig.1.5; (Hebner et al., 2008)].
Matrigel is a commercially availaboratoryle reconstituted or laminin-rich BM
(lrBM), which contains mainly laminin, type IV collagen, entactin and heparin
sulfate proteoglycan (Kenny and Bissell, 2003). Matrigel has been used
extensively for promoting ME cell differentiation in vitro, because ME cells are
surrounded by laminin-rich BM in vivo (Nelson and Bissell, 2006). However,
Matrigel is an ill-defined mixture of extracellular matrix proteins derived from an
Engelbeth-Holm-Swarm murine tumor (Kleinman et al., 1986). Matrigel thus has
an intrinsic variability and culture media containing serum or other supplements
may unpredictably interfere with its components. Our study has utilized the 3D
system by embedding an invasive breast cancer cell line into a 3D environment
composed of collagen I, similar to the model shown in the left panel of Fig.1.4.
We chose type I collagen because it is the major component of ECM that
invasive breast cancer cells contact when the BM is compromised, and it is
biologically better defined than Matrigel and can be easily manipulated.
An obvious limitation of 2D culture is lack of stroma, which accounts for
greater than 90% of the resting breast volume (Kim et al., 2004). This causes a
deficiency of organized architecture and limited transport. Normal ME cells grown
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in monolayer can be highly plastic and display tumor cell characteristics. The
major advantage of 3D over 2D culture is well-defined geometry, making
functional studies directly related to the microenvironment (Kim et al., 2004).
Besides resembling in vivo phenotypes, cell shape and mechanical force from
the microenvironment can also be studied, with the recognition that cell
behaviors are affected by these factors (Ghosh et al., 2008). Lastly, 3D cultures
support co-cultivation of multiple cell types so that ME-stromal cell interaction
can be examined (Gudjonsson et al., 2002).
The use of 3D cell culture systems allows better in vitro modeling of the
mammary gland. For example, when normal ME cells are plated in traditional 2D
cultures, they grow as monolayers and do not differentiate. When they are
cultured in 3D reconstituted BM, they form spherical acini in which milk is
secreted into a hollow lumen (Barcellos-Hoff et al., 1989). The normal ME cells in
the middle of the acini undergo apoptosis due to the lack of ECM contact. In
contrast, breast cancer cells grow continuously, resulting in disorganized
structures similar to those observed in the premalignant breast (Debnath and
Brugge, 2005a). In fact, culturing cells in 3D uncovered not only differences in
cell morphology, but also differences in growth rates, identity, quantity, and
patterns of expressed proteins between normal and breast cancer cells (Nelson
and Bissell, 2005). Using a 3D culture system has also been helpful to the
development of new therapy. Notably, Herceptin (i.e. An epidermal growth
factor (EGF) receptor blocking antibody) and Gleevec (i.e. a KIT-selective
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tyrosine kinase inhibitor) have been developed using 3D culture systems and
used successfully for cancer therapy (Kim et al., 2004).
Although these 3D systems mimic at least the minimum unit of the
mammary gland, the real microenvironment contains a variety of cell types and
thus more complicated interactions. As a result, the interpretation of data from
monotypic systems needs to consider their limitations.
1.5.2. Collagen I in the mammary microenvironment
The studies discussed thus far have shown that normal and cancer ME cell
behaviors are reproducibly distinguished in 3D culture models. In vivo, the breast
cancer microenvironment is dynamic in that tumor cells recruit numerous stromal
and immune cells that produce ECM proteins and other factors to create an
environment that favors cancer cell survival and metastasis (Hu and Polyak,
2008). Secretion of matrix metalloproteases (MMPs), fibroblast
transdifferentiation to myofibroblasts, and immune cell infiltration all facilitate BM
and interstitial matrix degradation, angiogenesis and subsequent invasion,
survival and growth (Weaver and Gilbert, 2004). One important change in the
interstitial matrix in breast cancer is increased breast density due to increased
deposition of collagen I and an increased number of fibroblasts. It is thought that
increased matrix stiffness due to these changes may promote cancer
progression through altering ECM receptors such as integrins and their
downstream signalling pathways. However, the precise mechanisms by which
stromal density alteration promotes breast cancer remain unknown (Erler and
Weaver, 2009). Fully differentiated myoepithelial cells and intact BM are often

19

lost during breast cancer progression from in situ to invasive carcinoma
(Gudjonsson et al., 2003).
There are more than 30 collagens and collagen-related proteins, with type
I collagen constituting about 90% of all collagens in the body (Velegol and Lanni,
2001).

Collagen I provides a scaffold to which other ECM components adhere.

The fundamental structure of collagen I is a long and thin rod-like protein about
300 nm long and 1.5 nm in diameter. Fibroblasts synthesize procollagen
molecules and collagen fibers begin to assemble in the endoplasmic reticulum
and Golgi, after cleavage of N-terminal and C-terminal propeptides from
monomeric collagen. The collagen molecules then polymerize to form collagen
fibrils. Collagen fibrils consist of 3 coiled subunits composed of two α1 chains
and one α2 chain. Each chain has 1050 amino acids wound around each other
in a characteristic right-handed triple helix. After a series of chemical
modifications, collagen fibrils are bundled, which enhances mechanical stability.
Collagen I forms fibrils spontaneously in vitro but not in vivo. Multiple factors
determine the sites and the initiation of collagen I fibrillogenesis in vivo, with
integrins involved in this process (Kadler et al., 2008). Type I collagen can be
obtained by extraction from rat tail tendon, bovine calf skin, and other sources by
acid digestion, and can form gels when returned to neutral pH in the
concentration range of 0.3-30 mg/ml (Pedersen and Swartz, 2005).
Cell proliferation has been studied in nontumorigenic ME cells in collagen
I-based 2D and 3D models. When collagen I was coated as a thin-layer at the
bottom of plastic dishes, both human primary ME and mouse ME cells showed
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robust cell proliferation regulated by α2β1 integrin-mediated signalling (Benaud
and Dickson, 2001c; Klekotka et al., 2001b). Mouse ME cells grown on floating
collagen gels, differentiated, forming alveoli and secreting casein in response to
hormones (Emerman et al., 1977). When a mouse ME cell line was grown in 3D
attached collagen gels, polarized acini formed (Soriano et al., 1995).
Morphogenesis as well as cell cycle progression of mouse ME cells, was
controlled by α2β1 integrin and growth factor signalling in 3D collagen culture
(Zutter et al., 1999). In contrast to mouse ME cells, human primary ME cells
cultured in 3D collagen I formed acini with inverse polarity. Addition of human
myoepithelial cells corrected the polarity (Gudjonsson et al., 2002). Correct
polarization in collagen gel has been reported for a number of other epithelial
cells, indicating that this inside-out polarity in collagen may be unique to normal
human ME cells (Gudjonsson et al., 2002).
Collagen cultures have also been used to study malignant ME cells. One
study observed that T47D and MCF-7 breast cancer cells were flat and
polygonal when grown as monolayers on plastic, but were spherical and formed
tumor-like aggregates in 3D collagen I (Leung and Shiu, 1982). However, T47D
cells differentiated into duct-like tubules when cultured in a floating 3D collagen
gel (Wozniak and Keely, 2005b).
Despite the extensive use of collagen in studying various types of cells
including malignant ME cells, there are few studies on the effects of 3D collagen
culture on proliferation of invasive breast cancer cells.
1.5.3. α2β1 integrin in the mammary microenvironment
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Integrins are the main receptors for the ECM, transmitting signals to and
from the cytoskeleton as well as activating signalling pathways that control cell
behavior. Specifically, cellular interactions with collagen I are mediated by
integrins, with α2β1 being the primary heterodimer on epithelial cells (McCallCulbreath and Zutter, 2008b).
The integrin family consists of 18 α and 8 β subunits forming 24 known
heterodimers dependent on cell type and function. Each integrin subunit has a
large extracellular domain, a short transmembrane domain and a small
intracellular domain. Different integrins interact with different substrates, but one
integrin can also interact with many substrates, and vice versa. α and β subunit
phosphorylation following ligand binding is thought to be involved in bi-directional
signalling. Cell adhesion via integrin engagement with the ECM results in
increased tyrosine phosphorylation of downstream proteins (Hehlgans et al.,
2007). One of the first proteins phosphorylated is focal adhesion kinase (FAK).
Focal adhesions form by recruiting a number of signalling and structural
molecules including FAK, Src, Phosphoinositide 3-kinases (PI3K), integrin linked
kinase, and Caveolin-1, among others. Activation of downstream signalling
pathways leads to the regulation of proliferation, differentiation, apoptosis,
migration, survival and angiogenesis (Hynes, 2002) .
The 5 collagen-binding integrins include α1β1, α2β1, α3β1, α10β1, and α11β1.
As a major collagen I receptor, α2β1 is expressed in epithelial cells, endothelial
cells, T cells, natural killer cells, and mast cells. α2β1 integrin knockout mice have
reduced mammary gland branching, delayed thrombus formation, and defective
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innate immunity (Hynes, 2002). Consistent with the knockout mouse model, in a
3D collagen I floating gel system, α2β1 integrin was found to have a role in
supporting branch elongation and cell migration for epithelial morphogenesis
(Zutter et al., 1999).
As discussed in the previous section, α2β1 integrin plays an important role
in cell cycle progression in nontumorigenic ME cells cultured in 2D or 3D
collagen. Studies have also addressed α2β1 integrin function in breast cancer cell
proliferation, although few of them used collagen cultures. When MCF-7 breast
cancer cells were treated with interferon-α, an inhibitor of cell proliferation, α2β1
integrin-mediated cell adhesion was reduced. Interferon-α had no effect upon the
cell surface expression of either α2 or β1 integrin (Maemura et al., 1999).
Overexpression of β1 integrin in several breast cancer cell lines increased the
phosphorylation of Akt and extracellular signal-regulated kinase (ERK),
promoting proliferation and bypassing the antiproliferative effects of Herceptin
used for EGF receptor positive breast cancer patients (Lesniak et al., 2009).
These studies indicate that β1 integrin participates in cell proliferation in both
normal and malignant ME cells by mediating cell adhesion and common
signalling pathways downstream of growth factors.
A transgenic mouse model of human breast cancer showed that β1
integrin plays an essential role in both the initiation and maintenance of breast
cancer growth in vivo (White et al., 2004). However, α2β1 integrin expression is
often diminished in breast cancer, correlating with breast cancer progression
(Zutter et al., 1993). Re-expression of this integrin reduced breast cancer
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formation in vivo (Zutter et al., 1995), implicating its reduction in breast cancer
etiology and progression. In contrast to these in vivo studies, studies with breast
cancer cells in 3D Matrigel showed that inhibition of β1 integrin function
decreased cell proliferation and reverted the malignant phenotype (Park et al.,
2006a; Weaver et al., 1997a). A more recent study showed that β1 integrin
inhibition was not sufficient to suppress tumor-matrix induced breast cancer cell
invasion (Castello-Cros et al., 2009). A better understanding of β1 integrin
function in breast cancer is required to clarify these discrepancies.
1.6. Hypothesis
Normal ME cells require attachment to the BM for survival. When integrinECM contact is disturbed, ME cells undergo a type of apoptosis termed anoikis.
Breast cancer cells often subvert anoikis, surviving without BM contact, allowing
them to invade the surrounding interstitial matrix once the BM is compromised.
Interestingly, tumor cells still depend on integrin-mediated signalling pathways. It
has been shown that integrin expression changes significantly during
tumorigenesis (Alexandrova, 2008), and this is also the case in breast cancer
(Koukoulis et al., 1991). β1 integrin regulates behavior of both normal and cancer
cells when they adhere to collagen, although the mechanisms are still under
investigation. We are interested in how a collagen I environment regulates breast
cancer cell proliferation, and the role of β1 integrin in this process. The ECM
primarily controls the expression of D-cyclins in early G1 phase of the cell cycle,
but cyclin E1 is also responsive to extracellular signals. In 2D collagen cultures,
α2β1 integrin stimulates the expression of cyclin E1 in nontumorigenic ME cells in
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a collagen I-dependent and cyclin D1-independent manner (Klekotka et al.,
2001a) . Our goal was to use a 3D collagen culture system to better model the
environment of invasive breast cancer cells in order to determine if this
environment directly regulates cyclin E1. We hypothesize that the breast
cancer microenvironment controls the cell cycle in part through direct
regulation of cyclin E1. Three specific aims test this hypothesis:

1. Evaluate how 3-dimensional collagen culture regulates the cell cycle in
malignant and non-tumorigenic ME cells.
2. Evaluate regulation of cyclin E1 by 2-dimensional versus 3-dimensional
collagen culture.
3. Define the mechanisms that regulate cyclin E1 within collagen cultures.
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1.7. Figures and Figure Legends

Figure 1.1 Three models of the mammalian cell cycle (Malumbres and
Barbacid, 2009).
In the currently accepted classical model, each of the main events during
interphase (G1, S and G2) is driven by cdks bound to specific cyclins. The
essential cell cycle model is based on genetic evidence that cdk1 is sufficient to
drive proliferation of all cell types up to midgestation and during adult liver
regeneration. The specialized cell cycles are based on the requirements of
specialized cell types for specific cdks.
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Figure 1.2 Integrin and growth factor cooperation in cell cycle regulation
(Miranti and Brugge, 2002).
Both growth factors and cell adhesion are required for transmitting signals
to the Ras/Raf/MEK/ERK signalling pathway. Activation of ERK and its nuclear
translocation results in an increase in cyclin D transcription. Cyclin D binds to
and activates cdk4/6. Integrins also stimulate degradation of the negative cell
cycle regulators (cdk inhibitors) p21 and p27, allowing the activation of cyclin
E/cdk2 complexes. Activation of both cdk4/6 and cdk2 is required for
hyperphosphorylation of retinoblastoma protein (Rb), causing the release of E2F,
which is required for increased transcription of cyclins E and A. Cyclin A/cdk2
complexes are required for S phase.
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Figure 1.3 The structure and function of the mammary gland are influenced
by communication with ECM and distant organs (Nelson and Bissell, 2006).
a. The human breast is a double-layered epithelial ductal tree (pink)
embedded in stroma. Distant organs release signals and influence ductal and
acinar morphogenesis. b. The epithelium is composed of a layer of luminal
epithelial cells (LEP) surrounded by myoepithelial cells (MEP) and enclosed by
BM. The epithelium is surrounded by an interstitial matrix and adjacent fatty
stroma.
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Figure 1.4 3D culture methods (Hebner et al., 2008).

Upper panel: Schematic of commonly used techniques. Left: Complete
embedding of ME cells in a matrix such as reconstituted BM (rBM) or type I
collagen. We used collagen in 3D culture similar to this method. Right: Mammary
epithelial cells seeded on a thin layer of solidified rBM are overlain with a dilute
solution of rBM in culture media.
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Figure 1.5 Advantages and disadvantages of several matrices for 3D
culture studies (Hebner et al., 2008).

The comparison between reconstituted BM and collagen I is discussed in
detail in section 1.5.1.
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2.

Chapter 2: Three-dimensional collagen inhibits the cell cycle
in breast cancer cells

2.1. Abstract
The

behavior

of

breast

epithelial

cells

is

influenced

by

their

microenvironment, which includes stromal cells and extracellular matrix (ECM).
During cancer progression, the tissue microenvironment fails to control
proliferation and differentiation, resulting in uncontrolled growth and invasion.
Upon invasion, the ECM encountered by breast cancer cells changes from
primarily laminin and collagen IV to primarily collagen I. We show here that
culturing breast cancer cells in 3-dimensional (3D) collagen I inhibits proliferation
through direct regulation of cyclin E1, a G1/S regulator that is overexpressed in
breast cancer. When the breast cancer cell line MDA-MB-231 was cultured
within 3D collagen I gels, the G1/S transition was inhibited as compared to cells
cultured on conventional 2D collagen or plastic dishes. Cells in 3D collagen
downregulated cyclin E1 protein and mRNA with no change in cyclin D1 level.
Cyclin D1 relocalized to the cytoplasm in 3D cultures and this was accompanied
by decreased phosphorylation of Rb, a nuclear target for both cyclin E1- and
cyclin D1-associated kinases. Positive regulators of cyclin E1 expression, the
transcription factor c-Myc and cold-inducible RNA binding protein (CIRP), were
decreased in 3D collagen cultures, while the collagen I receptor β1 integrin was
greatly increased. Inhibition of β1 integrin function rescued proliferation and
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cyclin E1 expression as well as c-Myc expression and Rb phosphorylation, but
had no effect on cyclin D1 localization. We conclude that cyclin E1 is repressed
independent of effects on cyclin D1 in a 3-dimensional collagen environment and
dependent on β1 integrin interaction with collagen I, reducing proliferation of
invasive breast cancer cells.

2.2. Introduction
Breast cancer is the most common cancer in American women and
remains second only to lung cancer as the leading cause of cancer-related
deaths among women. The information provided from traditional prognostic
factors such as age, lymph node status or tumor grade is often not precise
enough to tailor cancer diagnosis and treatment effectively. A better
understanding of breast cancer biology and identification of accurate prognostic
indicators and predictors of response based on the underlying molecular biology
could profoundly decrease metastatic death (Duffy and Crown, 2008; Lu et al.,
2009).
One important aspect of cancer biology is uncontrolled cell proliferation.
Events affecting checkpoints that govern transit through the first gap phase (G1
phase) of the cell cycle are observed frequently in human cancer. Cells are
responsive to extracellular signals at G1 phase to decide if cell division continues.
Cyclin E1, as regulator of re-entry into G1 from G0 (Geng et al., 2003) and the G1
to S phase (DNA synthesis) transition (Sherr and Roberts, 2004), has been
identified as a prognostic factor in breast cancer. Cyclin E1 is overexpressed in
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about 32% of breast tumors (Butt et al., 2005) where it is strongly predictive of
poor patient outcome and has been implicated directly in breast cancer etiology
(Keyomarsi et al., 1994; Potemski et al., 2009; Sieuwerts et al., 2006). Overall, a
more detailed understanding of cyclin E1 function in breast cancer biology is
needed in order to evaluate its potential as a therapeutic target, prognostic
marker and/or predictive marker.
Mammary epithelial (ME) cells respond to signals from the extracellular
matrix (ECM) by proliferating and differentiating into highly organized and
polarized glands, but in neoplastic progression, the microenvironment is altered
such that controls from the ECM are lost. The ECM primarily controls the
expression of D-cyclins in early G1 phase; however, cyclin E1 is also responsive
to extracellular signals (Cho et al., 2005; Henriet et al., 2000; Koyama et al.,
1996). α2β1 integrin, a receptor for collagen I and laminin, can stimulate
expression of cyclin E1 and cdk2 as well as cyclin E1/cdk2 complex formation in
ME cells in a collagen I-dependent and cyclin D1-independent manner (Klekotka
et al., 2001a). Based on this and the fact that breast cancer cells directly
encounter collagen I during invasion once the BM is compromised (Gudjonsson
et al., 2003; Ronnov-Jessen and Bissell, 2009), we set out to determine how a 3dimensional (3D) environment composed of collagen I regulates cyclin E1.
The invasive ME adenocarcinoma cell line MDA-MB-231 was cultured
either in conventional 2D monolayer on plastic or collagen I, or within a 3D
collagen gel to mimic the environment that invasive breast cancer cells
encounter as pericellular proteolysis begins. Our results demonstrate that β1
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integrin can inhibit the breast cancer cell cycle in a 3D collagen environment via
negative regulation of cyclin E1, a very different outcome as compared to a 2D
collagen environment.
2.3. Materials and Methods
2.3.1. Cell Culture
The human ME adenocarcinoma cell line MDA-MB-231 (HTB-26,
<passage 20) and nontumorigenic human ME cell line MCF10A (CRL-10317,
<passage 10) were obtained from American Type Culture Collection (ATCC,
Manassas, VA). Collagen I was prepared from rat tails using established
methods (Elsdale and Bard, 1972) and assessed for polymerization and cell
viability. Cells were cultured in 2D monolayer on plastic dishes (2DP), 2D
monolayer on plastic dishes coated with a thin (< 0.5mm) layer of 2.5% collagen
I (2DCI), or 3D culture within intact collagen I (3DCI, 0.5cm). 3D collagen cultures
were prepared as described with modifications (Wozniak and Keely, 2005a).
Collagen gelation was induced by incubating half of the collagen solution at 37°C
for 1h. Cells were suspended with the other half of liquid collagen and spread on
top of the gelled layer. After incubation at 37°C for 1h, complete medium was
added. Medium was changed every 2 days and cells were collected at 70-80%
confluency for experiments.
2.3.2. Cell cycle analysis
For analysis of asynchronous cells, cells were grown for 48h. Cells from
2D cultures were trypsinized and resuspended in complete media followed by
brief centrifugation. 3D collagen cultures were treated with 100U/ml highly
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purified collagenase (Collagenase VII, Sigma) for 20-30min at 37°C. Cell pellets
from the three culture conditions were analyzed by flow cytometry using Becton
Dickinson FACScan (San Jose, CA) and CellQuest software. For analysis of
synchronized cells, cells grown on 2DP and 3DCI to 50%-60% confluence were
synchronized in G1 by serum deprivation for 48h followed by 24h treatment with
5µg/ml aphidicolin. Synchronized cells were stimulated with serum and harvested
at the indicated times.
2.3.3. Western analysis
Whole-cell lysates were resolved by 10% SDS-PAGE and transferred
onto PVDF membranes. Membranes were blocked with 5% non-fat milk in TBS0.05% TWEEN20. Primary antibodies against cyclin E1, cyclin D1, HuR, and βactin (Santa Cruz Biotechnology, Santa Cruz, CA); CIRP (Proteintech Group,
Inc., Chicago, IL); Phospho-Rb(Ser780), total Rb and c-Myc (Cell Signaling
Technology, Danvers, MA); and β1-integrin (BD Biosciences, San Jose, CA)
were used. Blots were developed using SuperSignal West Pico
Chemiluminescent Substrate (Pierce, Rockford, IL). Images were captured using
Kodak Image Station 4000MM (Kodak Molecular Imaging) and intensities were
quantified by KODAK Molecular Imaging Software v4.0.
2.3.4. Real-Time PCR
Total RNA was isolated using Trizol (Invitrogen, Carlsbad, CA). Reverse
transcription was performed using oligo(dT)12-18 or random hexamers
(Invitrogen).. cDNAs were amplified by real-time PCR using SYBR Green PCR
Master Mix (Applied Biosystems, Foster City, CA). Relative quantification
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standard real-time PCR was carried out using an AB 7500 Fast Real-Time PCR
System with these conditions: 10min at 95°C, 40 cycles of 15sec at 95°C, 1min
at 60°C. Primers were: cyclin E1 and GAPDH as previously described (Guo and
Hartley, 2006); 18s rRNA, forward 5’-CGAACGTCTGCCCTATCAACTT-3’ and
reverse 5’-ACCCGTGGTCACCATGGTA-3’. Threshold cycles (Ct) were
normalized to GAPDH or 18s rRNA. Data were analyzed by Sequence Detection
Software 1.31.22 (Applied Biosystems). For mRNA stability assays, cells were
treated with 5µg/ml actinomycin D, total RNA extracted at the indicated time
following treatment, and real-time PCR performed to determine mRNA half-life.
2.3.5. Immunofluorescence analysis
Cells grown on glass coverslips in 24-well plates to 70% confluency
(Wozniak and Keely, 2005a) were incubated with primary antibodies against
cyclin D1, CIRP, HuR, or Ki-67 (BD Biosciences) and Alexa Fluor 488
conjugated secondary antibodies. Coverslips were mounted onto slides with
VECTASHIELD containing DAPI (Vector laboratoryoratories, Inc, Burlingame,
CA). Slides were analyzed using a Zeiss Axiovert 200M or a Zeiss LSM 510
Meta confocal microscope and associated software.
2.3.6. β1 integrin function blocking assay
MDA-MB-231 cells grown in 3D collagen for 24h were treated with media
containing AIIB2, a β1 integrin function-blocking antibody (Hall et al., 1990), for
2h and then collected for Western or immunofluorescence analysis. AIIB2
(Developmental Studies Hybridoma Bank, Iowa City, IA), or IgG1 as a control
were used at 0.24mg/ml as this concentration efficiently blocked β1 integrin
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function in MDA-MB-231 cells grown in Matrigel (Park et al., 2006b).
2.4. Results
2.4.1. 3D collagen culture inhibits cell cycle progression
To test if the ECM can control ME cell proliferation through direct
regulation of cyclin E1, MDA-MB-231 breast cancer cells were cultured in 2D
monolayer on plastic or collagen I, or within 3D collagen gels. We chose MDAMB-231 cells because cyclin E1 is highly expressed in these estrogen-receptor
negative, invasive cancer cells as compared to nontumorigenic ME cells, such as
MCF10A (Porter and Keyomarsi, 2000a). While MCF10A cells express only fulllength cyclin E1, MDA-MB-231 cells express both full length and low molecular
weight (LMW) isoforms, consistent with their tumorigenicity [(Harwell et al.,
2000), Fig. 2.2a].
Cell cycle phase distribution was obtained by flow cytometry of
asynchronized cells as shown in Fig. 2.1a. While 2D monolayer cells had a
similar cell cycle profile, in 3D collagen G1 phase cells increased by 5% while S
and G2/M cells both decreased by 6%. There was also a significant increase in
hypodiploid cells in 3D collagen (7.8%) as compared to 2D cultures (1%)
indicating increased cell death. This was further confirmed by DAPI staining
showing condensed and fragmented nuclei characteristic of apoptosis (data not
shown). The cell cycle profile was also analyzed in cells synchronized at the
G1/S border. Cells on 2D plastic were compared to cells in 3D collagen since 2D
asynchronized cultures showed similar cell cycle profiles. Synchronized cells on
2D plastic completed an entire cell cycle within 20h after serum stimulation (Fig.
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2.1b and c). In 3D collagen, there was a delay entering S phase (Fig. 2.1b and
c). While 49% of cells cultured in monolayer had entered S phase by 4h
following serum stimulation, only 10% of cells cultured in 3D had done so. By
20h, 47% of 3D cells were still in G0/G1 while 41% were in S phase.
Surprisingly, up to 72 hours after serum stimulation the majority of 3D cells
(45%) were still stagnant in G1/S and 14% of cells were hypodiploid (data not
shown). These data showed that 3D collagen I significantly delayed the G1/S
phase transition in synchronized cells.
Immunofluorescence analysis of Ki-67, a nuclear protein expressed by
cells in all phases of the cell cycle but absent in resting (G0) cells, was used to
assess proliferation index in the 3 culture conditions. Fig. 2.1d shows that 68%
of cells on 2D plastic, 77% of cells on 2D collagen and only 48% of cells in 3D
+
were Ki-67 . These data suggest that a 3D environment composed of collagen I

suppressed cell cycle progression by delaying entry into S phase and increasing
the G0 population.
2.4.2. 3D collagen downregulates cyclin E1 without changing cyclin D1
Since a significant G1/S delay was observed in cells cultured in 3D
collagen and cyclin E1 functions in the G1/S transition, we first examined
potential effects on cyclin E1. The relative level of cyclin E1 (full length and LMW
isoforms) was determined by western blotting and quantitated after normalizing
to β-actin (Fig. 2.2b). Cyclin E1 was decreased by 56% in 3D collagen compared
to 2D plastic (p<0.01) and 42% compared to 2D collagen (p<0.05), with no
significant difference between 2D cultures. Consistent with these results, real
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time RT-PCR showed that there was no significant difference in cyclin E1 mRNA
level between 2D cultures, while cyclin E1 mRNA was decreased by 71% in 3D
compared to 2D plastic (p<0.01) and 59% compared to 2D collagen (p<0.01)
(Fig. 2.2c). Thus inhibition of G1/S transition was accompanied by cyclin E1
downregulation.
Cyclin D1 regulates entry into and progression through G1 in response to
the extracellular environment (Diehl, 2002) by inactivating Rb, thus freeing E2F
for cyclin E1 transcriptional activation. Therefore, we assessed the cyclin D1
protein level. Cyclin D1 ran as a 37-kDa doublet, likely representing different
splice variants (Solomon et al., 2003). There was no significant difference in
cyclin D1 protein level between culture conditions (Fig. 2.2b), showing that the
decrease in cyclin E1 was not secondary to decreased cyclin D1.
2.4.3. Cyclin D1 relocalized from the nucleus to the cytoplasm in 3D

collagen culture
Since cyclin D1 is regulated by multiple mechanisms, including changes in
subcellular localization (Gladden and Diehl, 2005), its localization was also
assessed. Interestingly, cyclin D1 was predominantly nuclear in 2D cultures and
relocalized to the cytoplasm in 3D cultures (Fig. 2.3a). Since cyclin D1 exhibits its
regulatory function in the nucleus, its presence in the cytoplasm indicated a
potential continued activation of Rb and thus transcriptional downregulation of
cyclin E1, consistent with the decrease seen in cyclin E1 mRNA. To investigate if
cyclin D1 relocalization affected phosphorylation and thus activity of Rb, western
blotting was performed using an antibody recognizing Rb phosphorylated on

39

Ser780, a cyclin D-cdk4/6 phosphorylation site (Lundberg and Weinberg, 1998).
Ser780 phosphorylation was decreased in 3D as compared to 2D cultures as
was total Rb (Fig. 2.3b). There was also a significant increase of phospho-Rb in
2D collagen compared to 2D plastic, consistent with increased Ki-67 (Fig. 2.1d) in
2D collagen cultures.
2.4.4. Positive regulators of cyclin E1 were decreased in 3D collagen

culture
The transcription factor c-Myc is expressed in response to extracellular
signals such as mitogens and adhesion and induces expression of cyclin D,
cdk4, and E2F, among others. c-Myc was also reported to upregulate cyclin E1
in response to 2D collagen attachment (Benaud and Dickson, 2001a). Therefore,
we monitored the c-Myc protein level to determine if it was affected by 3D
collagen culture. 3D collagen culture decreased c-Myc levels by 26% compared
to 2D cultures (Fig. 2.3c), consistent with the increased G1 population,
decreased Rb phosphorylation, and decreased cyclin E1 mRNA.
In addition to transcriptional control, cyclin E1 mRNA stability is positively
regulated in breast cancer cells by the RNA binding proteins HuR and CIRP
(Guo and Hartley, 2006; Guo et al., 2009). To ask if regulation of these proteins
could also underlie changes in cyclin E1, we assessed their relative protein
levels. Western analysis showed no significant difference in HuR while CIRP was
decreased by 30% in 3D as compared to 2D cultures (Fig. 2.4a). CIRP and HuR
localization was also assessed as they shuttle from nucleus to cytoplasm to
stabilize their mRNA targets (Aoki et al., 2003; Brennan and Steitz, 2001). While
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HuR was primarily nuclear in all conditions, CIRP was cytoplasmic in
3D cultures (Fig. 2.4c and d). Despite this, cyclin E1 mRNA stability was not
significantly altered by 3D culture (Fig. 2.4b) showing that mRNA destabilization
did not contribute to the decrease in cyclin E1 mRNA. It is possible that either the
decrease in CIRP or its relocalization to the cytoplasm represses cyclin E1
translation (De Leeuw et al., 2007) or affects other CIRP target mRNAs to stall
G1 phase progression (Nishiyama et al., 1997).
2.4.5. β1 integrin mediated downregulation of cyclin E1
We next asked how 3D collagen could activate signalling pathways that
result in downregulation of cyclin E1. Cellular interactions with collagen matrices
are mediated by specific receptors, including integrins, with α2β1 integrin being
the primary heterodimer on epithelial cells (McCall-Culbreath and Zutter, 2008a).
Western blotting for β1 integrin was performed to see if protein levels differed in
the 3 culture conditions. As shown in Fig. 2.5a, there was a marked increase of
β1 integrin in 3D collagen. The nonspecific band below the integrin band was
observed in other cell lines (BD Biosciences, San Jose, CA) and did not change
between conditions. As α2β1 integrin is a collagen I receptor responsible for
delivering ECM signals to the cells (Klekotka et al., 2001a), and the cells were
surrounded by collagen I, increased β1 integrin was likely a functional adaptation
to this environment.
To determine if reduced cyclin E1 expression required β1 integrin
interaction with collagen I, a function-blocking antibody (AIIB2) that binds the β1
integrin extracellular domain was used to disrupt β1 integrin association with
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collagen (Hall et al., 1990; Park et al., 2006b). Cells were cultured in
3D collagen for 24h and then treated with AIIB2 or IgG1 (mock) for 2h. Cyclin E1
levels increased by 34% after blocking β1 integrin function and cell proliferation
increased by 10% compared to the mock group (Fig. 2.5b and d). Despite the
increase in cyclin E1, cyclin D1 remained cytoplasmic upon inhibition of β1
integrin (Fig. 2.5c), suggesting that effects on cyclin E1 were independent of
cyclin D1. Notably, there was a dramatic morphological change from spindle to
rounded cell shape after treatment, indicating that AIIB2 disrupted cell
attachment. Cell rounding was also observed in 2D cultures treated with AIIB2
(Fig. S1b), but cell proliferation was significantly decreased (Fig. S1a). These
results indicated that inhibition of β1 integrin association with collagen rescued
cell proliferation in 3D collagen cultures by upregulating cyclin E1 without
changing cyclin D1 localization. Blocking β1 integrin function also restored Rb
phosphorylation as well as Rb and c-Myc levels in 3D collagen culture (Fig. 2.6).
The increased phospho-Rb and c-Myc were in agreement with increased cyclin
E1 and increased cell proliferation upon inhibition of β1 integrin function.
2.5. Discussion

We have shown that a 3D environment composed of collagen I
suppresses proliferation of a highly aggressive human breast cancer cell line.
The suppression of proliferation resulted from a delay in S phase entry from G1
and an increase in G0 cells. Both cyclin E1 protein and mRNA were decreased,
consistent with the inhibition of G1/S transition, while cyclin D1 protein level was
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not affected. There was a dramatic shift in cyclin D1 localization from primarily
nuclear to cytoplasmic in 3D collagen, decreased phosphorylation of Rb, a
decrease in total Rb and c-Myc proteins, and a dramatic increase in β1 integrin, a
component of the collagen I receptor in epithelial cells. Inhibition of β1 integrin
function in 3D collagen increased cell proliferation and expression of cyclin E1,
Rb, phospho-Rb, and c-Myc, while cyclin D1 remained cytoplasmic. These
results show that cyclin E1 can be negatively regulated by the ECM downstream
of β1 integrin, bypassing cyclin D1.
β1 integrin has been implicated in positive regulation of ME cell
proliferation both in vitro and in vivo (Taddei et al., 2003), and is necessary for
formation of mammary tumors in murine models (White et al., 2004). Disruption
of β1 integrin function results in decreased ME cell proliferation in a transgenic
mouse model (Faraldo et al., 1998) and in both 2D and 3D tissue culture models
(Pasqualini and Hemler, 1994; Wang et al., 1998). Proliferation of an ME cell line
on 2D collagen was positively regulated via β1 integrin induction of c-Myc through
activation of the Src and MAPK (Mitogen-Activated Protein Kinase) signalling
pathways (Benaud and Dickson, 2001b). c-Myc upregulated cyclin E1
expression, downregulated the cyclin-dependent kinase inhibitor (CKI) p27, and
increased phosphorylation of Rb by cyclin E/cdk2 complexes (Benaud and
Dickson, 2001a). Similarly, in normal primary human ME cells, α2β1 integrin
interaction with a 2D collagen matrix stimulated expression of cyclin E1 and cdk2
as well as cyclin E1/cdk2 complex formation (Klekotka et al., 2001a). Consistent
with these studies, we noted that 2D collagen culture also increased proliferation
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of MDA-MB-231 breast cancer cells, while blocking β1 integrin reduced
proliferation. Likewise, when MDA-MB-231 cells were cultured in 3D Matrigel, a
reconstituted BM composed mainly of collagen IV and laminin, the addition of
inhibitory β1-integrin antibody reduced proliferation (Park et al., 2006b) and
reverted the malignant phenotype of HMT-3522 T4-2 breast cancer cells
(Weaver et al., 1997b). In contrast, nontumorigenic ME cells that form glandularlike structures in Matrigel, were resistant to β1 integrin inhibition. Neither
inhibiting apoptosis nor enhancing proliferation alone blocks lumen formation in
these epithelial structures, indicating that nontumorigenic ME cells and breast
cancer cells exert different mechanisms to maintain their phenotype in the same
environment (Debnath et al., 2002).
In contrast to 3D Matrigel, we show that 3D collagen culture inhibits
proliferation of MDA-MB-231 cells and blocking β1 integrin function rescues this
inhibition. Similar to the above studies, the mechanism is at least partially via
direct regulation of cyclin E1, as β1 integrin inhibition restores cyclin E1
expression as well as expression of c-Myc and phosphorylation of Rb without
influencing cyclin D1 level or cytoplasmic localization. Thus, our results also
implicate c-Myc in transcriptional regulation of cyclin E1 and cyclin E1/cdk2 in
phosphorylation of Rb. Results similar to ours were reported for arterial smooth
muscle cells, which arrest in G1 on the surface of polymerized collagen I and
proliferate on monomer collagen (Koyama et al., 1996). In this study, the CKI
p27 was induced and suppressed cyclin E1/cdk2 without changing cyclin E1
level. Although cyclin E1 was not studied, 3D collagen likewise arrested
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glomerular mesangial cells at G0/G1 phase (Tsuboi et al., 2000) associated with
downregulation of E2F and its targets, including c-Myc, and dephosphorylation of
Rb. Our findings add to these by showing that β1 integrin interaction with
collagen I can lead to negative regulation of cyclin E1, c-Myc and Rb. We did not
address the role of CKIs such as p27 since cyclin E1 level itself was reduced.
p27 is moderately expressed in MDA-MB-231 cells (Sweeney et al., 1998), thus
we cannot rule out a possible role in inhibiting cyclin E/cdk2 and/or other
cyclin/cdk complexes in 3D collagen, contributing to decreased proliferation.
To our knowledge, this is the first study to show cyclin D1 cytoplasmic
relocalization in response to 3D collagen. Cyclin D1 overexpression in cancer is
often caused by disruption of its degradation (Pontano and Diehl, 2008), which
has been shown to accelerate mammary carcinogenesis. At the G1/S boundary,
cyclin D1 is phosphorylated by GSK3β followed by nuclear export to the
cytoplasm, where cyclin D1 is recognized by SCFFbx4/αB-crystallin ligase,
ubiquitinated, and targeted to the 26S proteasome. Knockdown of either Fbx4 or
αB-crystallin inhibits cyclin D1 proteolysis and leads to its nuclear accumulation
and cell transformation (Barbash et al., 2008). MDA-MB-231 cells lack αBcrystallin due to a chromosomal deletion (Lin et al., 2008). In light of this, the
observation that in 3D collagen, cyclin D1 relocalized from the nucleus to the
cytoplasm and remained there after integrin inhibition, was surprising. Our
results suggest that cyclin D1 may be phosphorylated by GSK3β in response to
a 3D collagen environment, resulting in its inactivation by nuclear export. The
ability to directly regulate cyclin E1 in the absence of nuclear cyclin D1 may be
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an adaptation of MDA-MB-231 and other cancer cells for survival and growth in a
primarily collagen environment after invasion and during metastasis.
We had shown previously that the RNA binding proteins HuR and CIRP stabilize
cyclin E1 mRNA, contributing to its overexpression in breast cancer cells. As
microenvironment affects mRNA decay (Ross, 1995), we asked if these proteins
decreased in 3D collagen cultures. HuR did not change but CIRP decreased and
relocalized to the cytoplasm upon 3D collagen culture. Despite this, cyclin E1
mRNA half-life was not changed, suggesting that if the changes in CIRP
contribute to cyclin E1 downregulation it is via another mechanism (De Leeuw et
al., 2007) or effects on other targets.
In summary, our studies show that a 3D environment composed of
collagen I can control the cell cycle in part through negative regulation of cyclin
E1. This regulation is through β1 integrin-activated signalling pathways that
decrease c-Myc and ultimately result in downregulation of cyclin E1. The
downstream signalling pathways as well as the control of β1 integrin function in
inhibiting proliferation need to be further investigated.
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2.6. Figures and Figure Legends

Figure 2.13D collagen culture inhibits cell cycle progression.
P
CI
a Cell cycle analysis of asynchronous MDA-MB-231 cells in 2D , 2D , or

3DCI. Cell cycle phase distribution was obtained and percentage of gated cells in
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each phase were expressed as mean ± SD and assessed by Student’s t test; **p
P
< 0.01 vs. 2D ,

∆∆

p < 0.01 vs. 2DCI. b Cell cycle analysis of synchronized MDA-

MB-231 cells on 2DP or in 3DCI. Data is representative of 2 experiments. c
Percentage of synchronized cells in G0/G1 from B was plotted for the indicated
time points. d Quantitative analysis of proliferation in asynchronous cells.
Percentage of Ki-67+ cells was calculated by counting at least 10 40X fields (at
least 300 cells) per condition. **p < 0.01 vs. 2DP,
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∆∆

p < 0.01 vs. 2DCI

Figure 2.2 3D collagen culture downregulates cyclin E1 without changing
cyclin D1.
P
CI
CI
a Western blot of cyclin E1 in 2D , 2D and 3D MDA-MB-231 cells and
P
2D MCF10A cells. β-actin was used as a loading control. Representative of 2

experiments. b Western blots of cyclin E1 and cyclin D1 in 2DP, 2DCI and 3DCI
MDA-MB-231 cells. The relative quantity of cyclin E1 and cyclin D1 was
calculated after normalization to actin, expressed as mean ± SD and assessed
by Student’s t test. ∆p < 0.05 vs. 2DCI , **p < 0.01 vs. 2DP. c Cyclin E1 mRNA
level was determined by real-time RT-PCR. Threshold cycles (Ct values) were
normalized to GAPDH or 18s rRNA and plotted as relative mRNA levels. Values
were expressed as mean ± SD and assessed by Student’s t test.
2DP,

∆∆

p < 0.01 vs. 2DCI
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**p < 0.01 vs.

Figure 2.3 Cyclin D1 relocalized from the nucleus to the cytoplasm in 3D
collagen culture.
a Confocal images of cyclin D1 in MDA-MB-231 cells. Cyclin D1 staining
was visualized with Alexa Fluor 488 conjugated secondary antibody (green).
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Nuclei were stained with DAPI (blue). Magnification 63X. b Western blots of
P
CI
CI
phospho-Rb (Ser780) and Rb in 2D , 2D and 3D MDA-MB-231 cells. *p <
P
0.05 vs. 2D ,

∆∆

p < 0.01 vs. 2DCI. c Western blot of c-Myc in 2DP, 2DCI and 3DCI

of MDA-MB-231 cells. *p < 0.05 vs. 2DP,

∆∆

p < 0.01 vs. 2DCI. The relative

quantity of phospho-Rb, total Rb or c-Myc protein was calculated as in Fig. 2b
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Figure 2.4 CIRP was decreased and relocalized to the cytoplasm in 3D
collagen culture.
a Western blots for HuR and CIRP in 2DP, 2DCI and 3DCI MDA-MB-231
cells. ** p < 0.01 vs. 2DP. The relative quantity of HuR and CIRP proteins was
calculated as in Fig. 2b. b Half-life determination for cyclin E1 mRNA. Total RNA
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was extracted from cells grown on 2DP or in 3DCI at the indicated time after
addition of actinomycin D. Real time RT-PCR was used to analyze cyclin E1
mRNA level. Data were normalized to GAPDH mRNA or 18s rRNA and plotted
on a semi-logarithmic scale. c,d Confocal images of HuR and CIRP localization.
HuR or CIRP staining was visualized with Alexa Fluor 488 conjugated secondary
antibody (green). Nuclei were stained with DAPI (blue). Magnification 63X
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Figure 2.5 β 1 integrin was dramatically increased by 3D collagen culture.
a Western blot for β1 integrin in 2DP, 2DCI and 3DCI MDA-MB-231 cells.
**p < 0.01 vs. 2DP, ∆∆p < 0.01 vs. 2DCI. The relative quantity of β1 integrin protein
was calculated after normalization to actin, expressed as mean ± SD and
assessed by Student’s t test. b Western blot for cyclin E1 in 3DCI cultures of
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MDA-MB-231 cells with (AIIB2) or without AIIB2 (mock) antibody. *p < 0.05. c
CI

Confocal images of cyclin D1 in 3D

MDA-MB-231 cells with or without AIIB2

treatment (63X magnification). d Quantitation of Ki-67 in 3DCI MDA-MB-231 cells
+
with or without AIIB2 treatment. Percentage of Ki-67 cells was calculated by

counting at least 10 microscope fields at 40X (at least 600 cells) for each
condition. **p < 0.01
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Figure 2.6 β 1 integrin inhibition increased Rb and its phosphorylation as
well as c-Myc in 3D collagen.
a Western blots of phospho-Rb and total Rb in 3DCI cultures of MDA-MB231 cells with (AIIB2) or without (Mock) β1 integrin antibody. Cells were grown in
3DCI for 24h and then treated with AIIB2 or IgG1 for 2h. *p < 0.05. b Western blot
CI
of c-Myc in 3D cultures of MDA-MB-231 cells with or without AIIB2 antibody. *p

< 0.05. The relative quantity of phospho-Rb, total Rb or c-Myc was calculated as
in Fig. 2b
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Figure S 1 Supplementary data.
P
CI
CI
a Quantitation of Ki-67 in 2D , 2D and 3D MDA-MB-231 cells with or

without AIIB2 treatment. Percentage of Ki-67+ cells was calculated by counting at
least 10 microscope fields at 40X (at least 500 cells) for each condition and
repeated 3 times. **p < 0.01 vs. Mock 2DP,
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∆∆

p < 0.01 vs. Mock 2DCI, *p < 0.05

P #
CI
vs. AIIB2 2D , p < 0.05 vs. Mock 2D ,

##

p < 0.01 vs. Mock 3DCI. b Confocal

images of cyclin D1 in 2DP, 2DCI and 3DCI MDA-MB-231 cells with or without
AIIB2 treatment (63X magnification)
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3.

Chapter 3: The regulation of cyclin E1 in 3D collagen I by
Matrix Metalloproteinases

3.1. Abstract
Matrix Metalloproteinases (MMPs) have multifaceted roles in breast
cancer progression. In addition to promoting tumor metastasis through ECM
degradation, MMPs function in all steps of cancer progression through their
signalling functions including relieving proliferation suppression. Due to these
important roles of MMPs in breast cancer, we set out to determine if MMPs are
involved in cyclin E1 regulation within collagen cultures. The effects of
exogenous MMPs and MMP inhibitors on regulation of cyclin E1 by 3D collagen
were assayed. We found that exogenous addition of MMPs did not affect cyclin
E1 but endogenous MMPs were highly induced in 3D collagen. Inhibition of
these MMPs may rescue cyclin E1 suppression but did not change cyclin D1
localization in 3D collagen, suggesting negative regulation of cyclin E1 by MMPs
induced by 3D collagen culture.
3.2. Introduction
The presentation of an intact ECM is one of several mechanisms that
control ME cell proliferation in vivo (Jarvelainen et al., 2009). During cancer
invasion the ECM is degraded by several proteinases, including MMPs
(Brinckerhoff et al., 2000; Rudolph-Owen and Matrisian, 1998). Several MMPs
are highly expressed in breast cancer and invasive breast cancer growth is
preceded by an increase in MMP activity (Duffy et al., 2000). High levels of
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MMP-2 (Talvensaari-Mattila et al., 2003), MMP-9
MT1-MMP

(Mylona et al., 2007), and

(Jiang et al., 2006; Tetu et al., 2006) all have a poor prognostic

significance; while MMP-2 and -9 also have clinical value as diagnostic factors or
predictive factors of metastases (Jinga et al., 2006; Somiari et al., 2006a;
Somiari et al., 2006b).
In normal breast tissue, MMPs are tightly controlled to remodel the breast
microenvironment during mammary gland branching and involution. However,
during breast cancer progression, this normal control of MMP expression and
activity is lost (Strongin, 2006). MMPs have long been thought to associate with
late stages of tumor progression by promoting tumor metastasis through ECM
degradation. MMP association with cancer has been dramatically expanded with
evidence showing that MMPs function in all steps of cancer progression through
their signalling functions (Egeblad and Werb, 2002). These signalling functions
include release and/or activation of growth factors sequestered in the matrix or
complexed to associated proteins, cleavage of cell adhesion molecules, and
activation and /release of angiogenic factors and integrin subunits. MMPs thus
regulate tumor cell proliferation/apoptosis; the epithelial to mesenchymal
transition; angiogenesis and migration; and invasion and metastasis.
The sources of MMPs and their roles in breast cancer progression are
reviewed and summarized in Fig. 3.1(Chabottaux and Noel, 2007). We are
interested in how MMPs relieve proliferation suppression. This could be due to
removal of physical constraints, loss of ECM epitopes that suppress proliferation,
unmasking of epitopes that promote proliferation, changes in the

60

availaboratoryility of paracrine factors that suppress or promote proliferation,
and/or changes in cell shape that activate cross-talk between growth and
adhesion signalling networks (Chabottaux and Noel, 2007). In this study, we use
a 3D collagen culture system to determine if MMPs relieve proliferation
suppression via upregulation of the G1/S regulator cyclin E1.
Collagen I, a major ECM component, is degraded by several MMPs
including MMP-1, MMP-2, MMP-8, MMP-13, MT1-MMP, and MT3-MMP (Wolf et
al., 2007). A 3D collagen culture system has been used extensively to study the
contribution of MMPs to cancer cell migration and invasion (Barbolina et al.,
2007; Sarkar and Yong, 2009; Wolf and Friedl, 2009). However, few studies
have addressed the mechanism by which MMPs regulate cell proliferation. This
may be due to the fact that MMPs usually function extracellularly and the
observations that overexpressing several MMPs (MMP-1, -2, -3, -7, -9, -11, -13,
MT1-, MT2-, MT3-MMP) in epithelial cells cultured atop collagen I gel did not
alter cell proliferation (Hotary et al., 2000). In contrast, MT1-MMP conferred
breast cancer cells with a growth advantage by directly driving proliferative
responses within a 3D culture system rich in type I collagen, emphasizing the
importance of using well-defined 3D culture systems to study cancer cell
behaviors (Hotary et al., 2003).
MT1-MMP is also implicated in MMP-2 processing and its overexpression
induces ECM remodeling and tumor formation in the mammary glands of
transgenic mice (Ha et al., 2001). Cyclin D3-associated kinase activity increased
in MT1-MMP transfected squamous cell carcinoma cell line UM-SCC-1(Hotary et
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al., 2003). Similarly, impaired tyrosine phosphorylation of MT1-MMP in
human fibrosarcoma cell line HT-1080 induced growth arrest only in 3D collagen.
This growth arrest correlated with decreased cyclin D3 and Cdk4, and increased
p16, a cdk4/6 inhibitor, without changing cyclin D1 expression (Nyalendo et al.,
2008). MMP-9 and MMP-12 were shown to promote vascular smooth muscle cell
proliferation via increasing cyclin D1 expression through β-Catenin-mediated
signalling pathways (Dwivedi et al., 2009). Interestingly, siRNA against cyclin D1
decreased both MMP-2 mRNA and protein in non-small cell lung cancer along
with an inhibition of tumor growth and metastasis (Huang et al., 2009). Taken
together, these studies suggest a reciprocal regulation between MMPs and
positive cell cycle regulators, such as D-type cyclins.
Based on the observations that cell-ECM interactions may link
extracellular MMP function to the intracellular cell cycle machinery, and our
results showing that 3D collagen inhibits the breast cancer cell cycle by
decreasing cyclin E1 and bypassing cyclin D1 (Chapter 2), we sought to
investigate if a 3D collagen environment decreases cyclin E1 via downregulation
of MMPs. To address this question, the effects of exogenous MMPs and MMP
inhibitors on regulation of cyclin E1 by 3D collagen were assayed. We also stably
expressed MT1-MMP in the MDA-MB-231 cell line to see if cyclin E1
downregulation in 3D collagen was rescued (Appendix, Fig.1). As cyclin D1 was
previously shown to be regulated by MMPs, we also assayed effects on cyclin
D1.
3.3. Materials and Methods
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3.3.1. MMP treatment
MMP-1, MMP-2 and MMP-9 were purchased from R&D Systems
(Minneapolis, MN) and activated according to the product instructions. 2D plastic,
2D collagen and 3D collagen culture conditions are described in Chapter 2,
section 2.3.1. MDA-MB-231 cells were cultured on 2D plastic with addition of
soluble activated MMP-1, MMP-2 and MMP-9 as a pilot experiment before
adding MMPs into 3D collagen cultures. Cells cultured within 3D collagen were
incubated with no addition, TCNB (Tris, CaCl2, NaCl, Brij35) buffer, or increasing
amounts of MMPs in TCNB buffer in serum-free media at 37°C for 4h before
lysis.
3.3.2. Western and Immunofluorescence Analyses

Western blotting for cyclin E1 was performed as described in Chapter 2,
section 2.3.3. Cyclin D1 immunofluorescence assay was performed as in
Chapter 2, section 2.3.5.
3.3.3. MMP Zymography
Conditioned media were collected from cells cultured on 2D plastic, 2D
collagen, and within 3D collagen for 24h in serum-free medium. Endogenous
MMP-2 and MMP-9 activities were assayed by substrate zymography with
conditioned media. Briefly, SDS-polyacrylamide gels were co-polymerized with
1mg/ml gelatin. Samples were normalized by an equal cell number and loaded
without reductant. Gels were washed with 2.5% Triton X-100 for 5min at room
temperature and rinsed with water. Gels were then incubated for 24-48h in a
buffer containing 50mM Tris-HCl, pH 7.6, 200mM NaCl, 5mM CaCl2, 0.02% Brij63

35 and 0.02% NaN3 (TCNB), stained with Coomassie Blue and destained with
10% acetic acid.
3.3.4. MMP activity inhibition
To inhibit endogenous MMP activity, cells were incubated with serum free
medium containing 30µg/ml BB94 (a gift from Dr. Paul McGuire, UNM-HSC) for
24h and then collected for western blotting or immunofluorescence assays. We
used 30µg/ml BB94 for 24h because this treatment condition reduced MMP
activity in the conditioned media to basal levels in a pilot time course enzyme
activity assay, in which cleavage of a fluorogenic peptide substrate ES010 by
MMPs in the conditioned media with or without serial concentrations of BB94 for
different periods of time was measured and compared (data not shown).
3.4. Results
3.4.1. Exogenous MMPs did not alter cyclin E1 protein level

MDA-MB-231 cells overexpress cyclin E1 and its tumor-associated low
molecular weight (LMW) isoforms. We showed previously that cyclin E1
expression was reduced when MDA-MB-231 cells were grown within 3D
collagen, as compared to cells grown on 2D plastic or collagen-coated dishes.
Reduction of cyclin E1 by 3D collagen required interaction of β1-integrin with the
collagen matrix. As discussed above, a reciprocal regulation between MMPs and
positive cell cycle regulators has been observed. Collagen I can be degraded by
MMPs and MMPs can also regulate cell motility through activating integrin
subunits such as β3(Deryugina et al., 2002). Whether MMPs can regulate cyclin
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E1 through integrin-mediated pathway in collagen is unknown. In order to
determine if we could rescue cyclin E1 expression in 3D collagen by adding
MMPs, we first needed to confirm that cyclin E1 levels in 2D cultures would not
be affected by MMP addition as they already highly express MMPs. MDA-MB231 cells grown on 2D plastic dishes were incubated with exogenous MMP-1,
MMP-2 and MMP-9 for 24h before collection. Cells without any addition (control)
or with buffer (TCNB) alone were collected as controls. Indeed, there was no
change in cyclin E1 protein level upon treatment with increasing amounts of
MMP-1, MMP-2, or MMP-9 (Fig. 3.2a). However, when cells cultured in 3D
collagen I were treated with MMP-1, no change was observed in cyclin E1 level
either (Fig. 3.2b), although cyclin E1 level appeared higher than 2D plastic due to
blot overexposure. Therefore, exogenously adding soluble active MMPs did not
affect cyclin E1 level in 2D plastic or in 3D collagen MDA-MB-231 cells.
3.4.2. Endogenous MMP-2 and MMP-9 were increased in 3D collagen

cultures
Although exogenous MMPs did not appear to affect cyclin E1 in collagen
cultures, breast cancer cell lines including MDA-MB-231, were found to activate
serum-derived MMP-2 independent of MMP-2 production when they were plated
on collagen I gels (Azzam et al., 1993). Therefore, we investigated whether
these cells secret and activate MMPs when cultured in 3D collagen I. We looked
at endogenous MMP expression and activity by zymography assays. 3D collagen
not only induced pro-MMP-2 and pro-MMP-9 expression but also significantly
increased active MMP-2 and MMP-9 levels (Fig. 3.3). Interestingly, 2D collagen
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also increased pro-MMP-9 and MMP-9 expression as compared to 2D plastic.
Although pro-MMP-2 was not increased in 2D collagen cultures compared to 2D
plastic, active MMP-2 was significantly higher in 2D collagen cultures. These
results show that a collagen environment significantly induced endogenous
MMP-2 and MMP-9 expression and activity, with 3D collagen having the greatest
effect.
3.4.3.

Endogenous MMPs may participate in altering cyclin E1 level

To determine if the upregulation of MMPs was necessary for
downregulation of cyclin E1 in 3D collagen cultures, we inhibited endogenous
MMP activity by adding a broad-spectrum MMP inhibitor (BB94, Batimastat) to
the culture media. While the cyclin E1 level in 2D cultures was similar with or
without BB94, the decrease seen in cyclin E1 upon 3D culture (∗∗p<0.01 vs. 2DP
in serum free media) was partially rescued upon BB94 treatment. This rescue
trended towards significance, with a p value of 0.05 (Fig. 3.4). The variability in
cyclin E1 level in 3D BB94 treated cultures could result from the variable
penetration of BB94 through the 3D collagen between independent experiments,
as MMP could be trapped in the collagen gel (Azzam et al., 1993).
3.4.4. Inhibition of MMP activity did not alter cyclin D1 localization in 3D

collagen
In addition to reducing cyclin E1 expression, culturing cells in 3D collagen
also changed the localization of cyclin D1 from the nucleus to the cytoplasm (Fig.
2.3), which would results in inactivation of its associated kinase. This
relocalization was not dependent on β1 integrin interaction with the matrix and did
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not appear to be causal for reducing cyclin E1. Since MMPs are known to
upregulate cyclin D1 and its associated kinase, we asked if inhibition of MMP
activity in 3D collagen would reverse cyclin D1 relocalization. As shown by
immunofluorescence analysis (Fig. 3.5), Cyclin D1 remained cytoplasmic upon
BB94 treatment of cells in 3D collagen. This experiment indicated that cyclin D1
re-localization in 3D collagen was independent of endogenous MMP activity.
3.5. Discussion
Our results in Chapter 2 showed that 3D collagen I reduced cyclin E1
expression as compared to 2D cultures and this reduction required cell-collagen
interaction through β1 integrin. 3D collagen I also re-localized cyclin D1 and this
did not appear to be dependent on β1 integrin or the cause for cyclin E1
suppression. MMPs are highly expressed in breast cancer and have multiple
functions in tumor etiology and a poor prognostic significance, mainly because of
their enzymatic degradation of ECM, including type I collagen (Chabottaux and
Noel, 2007). MMPs have also been suggested to positively regulate the cell cycle
regulators, as well as to activate integrins to facilitate tumor cell behaviors. We
set out to determine if MMPs are involved in the regulation of cyclin E1 by 3D
collagen. Specifically, we asked if 3D collagen environment decreases cyclin E1
via downregulation of MMPs. We found that exogenous addition of MMPs did not
affect cyclin E1 but endogenous MMPs were highly induced in 3D collagen.
Inhibition of these MMPs may rescue the cyclin E1 suppression but did not
change cyclin D1 localization in 3D collagen, suggesting a negative regulation
between MMPs and cyclin E1 without changing cyclin D1.
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The finding that adding soluble MMPs into 3D collagen cultures did not
change cyclin E1 level was not surprising because as a highly invasive breast
cancer cell line, MDA-MB-231 cells were recently reported to express 26 MMPs.
These MMPs include the 3 used in our study, which enhance invasiveness
(Hegedüs, L, 2008). As a result, exogenous MMPs may not have any effect due
to constitutively high expression of MMPs by MDA-MB-231 cells.
We did observe a robust increase of MMP-2 expression and activity in 3D
collagen compared to both 2D plastic and 2D collagen cultures. This is intriguing
since it was previously reported that MMP-2 mRNA was not detectable in MDAMB-231 cells cultured on 2D plastic (Morini et al., 2000). However, MMP-2
mRNA was increased when MDA-MB-231 cells were grown in Matrigel compared
to 2D plastic cultures (Figueira et al., 2009). Consistently, culturing ovarian
cancer cells on 3D collagen stimulated activation of pro-MMP-2 (Ellerbroek et al.,
1999). Both of these cell types bind to collagen via β1 integrins and integrin
clustering stimulates MT1-MMP expression and activation, which ultimately
promotes MMP-2 processing (Ellerbroek et al., 2001). In our study, β1 integrin
was significantly increased in 3D collagen (Fig. 2.5), suggesting that MDA-MB231 cells possibly activate MMP-2 through β1 integrin-mediated interaction with
collagen I. MT1-MMP is a membrane-type MMP and is present and active on the
cell surface (Barbolina and Stack, 2008). Therefore, the role of MT1-MMP in
suppression of cyclin E1 and upreguation of MMP-2 in 3D collagen needs further
study. We have successfully cloned MT1-MMP from nontumorigenic MCF10A
ME cells (Appendix, Fig. 6.1). We will first monitor MT1-MMP expression and
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activity in 3D collagen. If MT1-MMP expression and activity is similarly high as
MMP-2 and MMP-9 in 3D MDA-MB-231 cells, MT1-MMP catalytic inactive
mutants based on this clone can be used to see if downregulation of MT1-MMP
will rescue cyclin E1 reduction.
We also showed that MMP-9 expression and activity was induced by both
2D and 3D collagen. MMP-9 has been found to be highly expressed and directly
involved in MDA-MB-231 cell invasion in 2D cultures (Morini et al., 2000).
Function blocking α3β1 integrin antibody inhibited MDA-MB-231 cells migration
and invasion, correlating with a reduction of MMP-9 activity. However, how
blocking integrin function led to reduced MMP-9 was not addressed. Our results
show that MMP-9 is induced to an even higher level by 3D as compared to 2D
collagen culture in MDA-MB-231 cells, accompanied by increased expression of
β1 integrin. These results suggest that β1 integrin-mediated regulation of MMP-9
may be different between 2D and 3D culture systems. They also suggest that
upregulation of β1 integrin may result in increased MMP-9 expression and
activity, when breast cancer cells are embedded in 3D collagen. It has been
shown that 3D collagen increases MMP-9 expression and activation in hepatic
stellate cells via activation of the ERK signalling pathway (Takahara et al., 2003).
The effect on MMP-9 was inhibited by neutralizing antibody against α2β1 integrin,
tyrosine kinase inhibitors, or a MEK inhibitor. Whether MMP-9 was induced
through similar signalling pathways and which α integrin subunit (α2 or α3) was
functioning in our model needs to be further investigated.
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Increased MMP-2 and MMP-9 expression and activity in 3D collagen
cultures of MDA-MB-231 cells also correlated with suppressed cell proliferation
and a decrease in cyclin E1. The decrease seen in cyclin E1 upon 3D culture
was rescued upon MMP inhibition, with a trend towards significance (p = 0.05).
This was independent of effects on cyclin D1 since it remained cytoplasmic upon
BB94 treatment (Fig.3.5).
Among its many functions, integrin is also involved in tumor invasion (Gui
et al., 1995; Jia et al., 2004; Strizzi et al., 2004) and metastasis (Brakebusch et
al., 1999; White and Muller, 2007). Since tumor cells do not appear to undergo
invasion and proliferation simultaneously (Jung et al., 2001; Koochekpour et al.,
1995; Palmqvist et al., 2000; Svensson et al., 2003), the increase seen in β1
integrin and MMPs coupled to decreased cell proliferation in 3D collagen cultures
might indicate a cell behavior transition from growth to invasion. In a recent
study, 8 determinants of cancer cell invasiveness that are located upstream of
MMPs in cell signaling pathways were transiently overexpressed in MDA-MB-231
cells, and alterations of 9 different MMPs (including MMP-2, MMP-9, and MT1MMP) mRNAs were seen (Delassus et al., 2008). Each of these determinants
regulated MMP expression through different sets of signaling pathways, resulting
in identification of 20 new pathway links including 5 in breast cancer. Notably,
many components of the cell signalling pathways linking these upstream
determinants and MMPs are also involved in integrin-mediated signalling
pathways, such as the Ras/Raf/MEK/MAPK/ERK shown in Fig.1.2. Future
experiments will determine whether MDA-MB-231 cells become more invasive in
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3D collagen and which integrin-linked signalling pathways regulate both MMP
activity and cyclin E1.
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3.6. Figures and Figure Legends

Figure 3.1 The sources and implication of MMPs in breast cancer
progression. Modified from Fig. 2 in (Chabottaux and Noel, 2007).
Top panel indicates the sources of MMPs within the breast cancer
microenvironment. 1)-4) refer to breast cancer cell behaviors during breast
cancer progression. Boxes with arrows show the contributions of MMPs to each
behavior and the possible mechanisms.
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Figure 3.2 Exogenous MMPs did not change cyclin E1 protein level.
a. Western blotting for cyclin E1 in MDA-MB-231 cells cultured on 2D
plastic and treated with the indicated MMPs in increasing concentration in
serum-free media at 37°C for 4h before lysis. Controls were no addition (con) or
buffer alone (TCNB). Blots are representative of 2 experiments. b. Western
blotting for cyclin E1 in MDA-MB-231 cells cultured in 3D collagen and treated
with 40 nM MMP-1 before lysis. Blot is representative of 2 experiments
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Figure 3.3 Endogenous MMP-2 and MMP-9 expression and activation by 2D
and 3D collagen culture.
Conditioned media were collected from MDA-MB-231 cells cultured on 2D
plastic (2DP), 2D collagen (2DCI), or within 3D collagen (3DCI) for 24h in serumfree medium. Endogenous MMP-2 and MMP-9 activities were assayed by
1mg/ml gelatin substrate zymography with conditioned media. The volumes of
conditioned media loaded was normalized to an equal cell number in each
condition. HT1080 cell conditioned medium was used as a positive control. The
relative quantity of pro-MMPs and MMPs were measured by intensity analysis on
a Kodak imager system, expressed as mean ± SD, and assessed by Student’s t
test.

∆∆

p < 0.01 vs. 2DCI , **p < 0.01 vs. 2DP. Results are representative of 5

experiments
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Figure 3.4 Endogenous MMP activity may regulate cyclin E1
level.
P
CI
MDA-MB-231 cells cultured on 2D plastic (2D ), 2D collagen (2D ), or

within 3D collagen (3DCI) were incubated with serum free medium alone or
containing 30µg/ml BB94 for 24h and then collected for cyclin E1 western
blotting. The relative quantity of cyclin E1 was calculated after normalization to
actin, expressed as mean ± SD and assessed by Student’s t test. **p < 0.01 vs.
2DP. Results are representative of 4 experiments
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Figure 3.5 Inhibition of MMPs did not alter cyclin D1 cytoplasmic
localization in 3D collagen cultures.

Confocal images of cyclin D1 localization after BB94 treatment of 3D
collagen cultures of MDA-MB-231 cells. Cells were incubated with serum free
medium containing 30µg/ml BB94 for 24h and then fixed. Immunofluorescence
assay for cyclin D1 was performed as described in Chapter 2, section 2.3.5.
Cyclin D1 staining was visualized with Alexa Fluor 488 conjugated secondary
antibody (green). Nuclei were stained with DAPI (blue). Magnification 63X

76

4.

Chapter 4: Regulation of cyclin E1 by 3D collagen in
nontumorigenic MCF10A and tumorigenic HMT-3522 T4-2
mammary epithelial cells

4.1. Abstract
To address the hypothesis that cyclin E1 inhibition by a 3D collagen
environment occurs in both nontumorigenic and tumorigenic ME cells other than
MDA-MB-231 cells, we assayed effects of 3D collagen culture on the cell cycle
and cyclin E1 level of nontumorigenic MCF10A and tumorigenic HMT-3522 T4-2
ME cells. Results showed that an ECM composed of collagen I negatively
regulates the cell cycle in part through downregulation of cyclin E1 in these cell
lines, similar to what we have shown for MDA-MB-231 cells. In contrast to the
tumorigenic cell lines, MCF10A cells underwent a global G1 arrest followed by
apoptosis. These results suggest that tumorigenic ME cells are better adapted
for survival in a 3D collagen environment.

4.2. Introduction
All of the data shown thus far are based on one invasive breast cancer
cell line, MDA-MB-231, thus limiting the impact of our results. To begin to
determine if the general model that an ECM composed of collagen I negatively
regulates the ME cell cycle in part through downregulation of cyclin E1, we used
the nontumorigenic ME cell line MCF10A and the malignant ME cell line HMT3522 T4-2 (T4-2).
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In this study, we addressed the hypothesis that cyclin E1 inhibition by a
3D collagen environment occurs in both tumorigenic and nontumorigenic ME
cells. We proposed that the tumorigenic cells are able to partially overcome this
inhibition by upregulating β1-integrin, a collagen receptor, thus adapting
themselves to this environment. We assayed effects of 3D collagen culture on
the MCF10A cell cycle and on cyclin E1 levels in MCF10A and T4-2 cells.
Results suggested that our model held true for the ME cells studied.
4.3. Materials and Methods
4.3.1. Cell Lines
The T4-2 cell line was a generous gift from Dr. Mina Bissell (Lawrence
Berkeley National Laboratoryoratory) and was maintained on 2D collagen as
recommended (Blaschke et al., 1994). MCF10A and MDA-MB-231 cells were
cultured as described in Chapter 2, section 2.3.1.
4.3.2. Cell Cycle Analysis
MCF10A cells grown in 3D collagen were synchronized at G1/S boundary
by serum deprivation for 48h followed by 24h treatment with 5µg/ml aphidicolin in
order to obtain cell cycle profile by FACS. The FACS profile of synchronous
MCF10A cells on 2D plastic was provided courtesy of Dr. Xun Guo (UNM-HSC)
and published (Guo and Hartley, 2006). Cells grown on 2D plastic were
synchronized and collected by the same method.
T4-2 cell proliferation was assessed by immunofluorescence analysis with
an antibody recognizing phosphorylation of serine 10 of histone H3.
Phosphorylation of histone H3 begins at the end of S phase, is maximal in M
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phase and is rapidly lost as cells enter G1. Phospho-Histone-H3 (Ser 10)
antibody was from Upstate Biotech (Millipore Corporate,Billerica, MA). Cells were
grown in 2D collagen or 3D collagen with glass coverslips in 24-well plates to
70% confluency (Wozniak and Keely, 2005a), then incubated with phosphoHistone-H3 (Ser 10) antibody and Alexa Fluor 488 conjugated secondary
antibodies. Coverslips were mounted onto slides with VECTASHIELD containing
DAPI (Vector laboratoryoratories, Inc, Burlingame, CA). Slides were analyzed
using a Zeiss Axiovert 200M microscope and associated software. Percentage of
phospho-H3 positive cells was calculated by counting at least twenty 40X fields
(at least 500 cells) per condition. For assays of apoptosis, cells were fixed and
nuclei were stained with DAPI in order to visualize morphology. Percentage of
apoptotic cells was calculated by counting condensed and fragmented nuclei
characteristic of apoptosis, at least 20 40X fields (at least 500 cells) per
condition.
4.3.3. Cyclin E1 mRNA analysis
The Cyclin E1 mRNA level was studied by quantitative real-time PCR
and protein level by western analysis as described in Chapter 2, sections 2.3.3
and 2.3.4.
4.4. Results
4.4.1. 3D collagen arrested MCF10A cells in G1
When tumorigenic MDA-MB-231 cells were cultured in 3D collagen, the
G1 population increased, consistent with the decrease seen in cyclin E1. To
determine if 3D collagen culture had similar effects on nontumorigenic ME cells,
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MCF10A cells were cultured in 3D collagen I, synchronized at the G1/S
boundary, and the cell cycle profile assessed by FACS (Fig. 4.1b). We had
previously shown that synchronous MCF10A cells cultured on 2D plastic have a
rapid cell cycle of 10-12 h [Fig. 4.1a, (Guo and Hartley, 2006)]. In contrast, when
cultured within 3D collagen, MCF10A cells arrested in G1 and hypodiploid cells
increased in a time-dependent manner, indicating continuous cell death. For
example, when the majority of the 2D MCF10A cells were in S phase at 4h after
serum addition (79%), only 6% of 3D cells were in S phase and 37% were
hypodiploid. By 10h, when 2D cells had almost completed the cell cycle, 37% of
the 3D cells were still in G0/G1 phase and 50% of the cells were hypodiploid.
Although these results are preliminary (the experiment was performed once),
there appears to be a major difference in response to 3D collagen culture
between nontumorigenic MCF10A and tumorigenic MDA-MB-231 cells, with a 510% increase in the G1 population in tumor cells and at most 10% hypodiploid
cells, while the majority of nontumorigenic cells underwent G1 arrest and
subsequently died (Fig. 4.3a-b and Fig. 2.1).
4.4.2. Collagen culture decreased cyclin E1 mRNA level in MCF10A

cells
We next asked if a decrease in cyclin E1 accompanied the nearly global
G1 arrest. Real time RT-PCR showed that there was a significant decrease in
cyclin E1 mRNA levels in MCF10A cells cultured on both 2D collagen (35%) and
3D collagen (48%) compared to 2D plastic. These results suggest that a type I
collagen environment might inhibit cyclin E1 transcription (Fig. 4.2). We have not
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yet assessed cyclin E1 protein level, but based on results with MDA-MB-231
cells in which the decrease of cyclin E1 mRNA was always accompanied by
decreased protein (Fig. 2.2), and on the fact that cyclin E1 is a very unstable
protein, we expect that cyclin E1 protein level will also be decreased. This will be
investigated in future experiments.
4.4.3. 3D collagen effects on tumorigenic T4-2 cells.
To determine if 3D collagen would have similar effects on a different
tumorigenic ME cell line, we studied the malignant breast cancer cell line HMT3522 T4-2. We chose this cell line because it has a genetically matched
nontumorigenic ME cell line HMT-3522 S1 (S1) with the same origin (Debnath
and Brugge, 2005b). Due to technical difficulties in growing the cells, data from
these nontumorigenic S1 cells have not yet been obtained. T4-2 cell proliferation
was assessed by immunofluorescence analysis for phosphorylated serine 10 of
histone H3, a mitotic cell marker. As T4-2 cells are routinely maintained on 2D
collagen, 2D collagen data was compared to that of cells embedded in 3D
collagen. As shown in Fig. 4.3b, 6.5% of cells were undergoing mitosis on 2D
collagen but only 1.5% in 3D collagen. We also assessed apoptosis by DAPI
staining followed by counting condensed and fragmented nuclei. Only 0.3% of
cells showed characteristics of apoptosis on 2D collagen, while about 20%
appeared apoptotic in 3D collagen. Although this experiment needs to be
repeated, it is consistent with MDA-MB-231 data in which mitosis decreased and
apoptosis increased in 3D as compared to collagen (Fig. 4.3a).
4.4.4. 3D collagen decreased LMW cyclin E1 in T4-2 cells
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As preliminary data indicates that proliferation of T4-2 cells is decreased in
3D collagen, we next investigated cyclin E1 protein level by western analysis.
Although full length cyclin E1 level was not significantly affected, the 40kDa
LMW isoform of cyclin E1 was decreased by 70% in 3D collagen compared to
2D collagen culture (Fig. 4.4). The decrease of this LMW isoform was also seen
in MDA-MB-231 cells, where 3D collagen significantly decreased by 77% (data
not shown), although it was accompanied by a decrease of full-length cyclin E1.
This result indicated that 3D collagen generally suppressed breast cancer cell
proliferation at least partly through downregulation of cyclin E1.
4.5. Discussion
We showed previously that a 3D collagen environment suppresses
synchronous breast cancer MDA-MB-231 cell proliferation by significantly
delaying the G1/S phase transition. We have now shown that in the same 3D
collagen environment, synchronous nontumorigenic MCF10A cells arrest in
G0/G1 phase and subsequently die. This cell cycle arrest was accompanied by
decreased cyclin E1 mRNA, indicating that the mechanism for cell cycle arrest
may be similar in these cells. MDA-MB-231 cells underwent limited apoptosis in
both asynchronous (about 10%, Fig. 4.3a) and synchronous 3D collagen cultures
(about 5%, Fig. 4.3b and Fig. 2.1). The increase in cell death in MCF10A cells
suggests that nontumorigenic ME cells are either more sensitive to a collagen
environment or that tumorigenic cells are more adaptable, as suggested by their
ability to upregulate β1 integrin (Fig. 2.5). When deprived of an appropriate ECM,
i.e. BM in vivo, ME cells undergo detachment-induced apoptosis, a process
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termed anoikis (Debnath and Brugge, 2005b). In contrast, breast cancer cells
survive independent of attachment (Simpson et al., 2008). Our results are
consistent with this, as nontumorigenic MCF10A arrested and died while the
majority of MDA-MB-231 breast cancer cells survived in 3D collagen I, probably
via upregulation of β1 integrin. Although consistent with cell cycle arrest, the
decrease of cyclin E1 mRNA in MCF10A cells could also be a result of cell
death. It has been shown that under genotoxic stress, caspase-mediated
cleavage of cyclin E1 generated a p18-cyclin E fragment in hematopoietic tumor
cells. This fragment is unable to interact with cdk2 but can sensitize cells to
apoptotic stimuli (breast ME cells were not studied), indicating a role for cyclin E1
in regulation of apoptosis (Mazumder et al., 2007). We have not seen this cyclin
E1 fragment in MDA-MB-231 cells but we cannot exclude its possible role in
promoting MCF10A cell apoptosis under the stress of a 3D collagen
environment. Western blotting for cyclin E1 will be the first step to examine the
existence of this cyclin E1 fragment.
Since MCF10A cells have a different genetic background from MDA-MB231 cells, it is possible that the difference in response to a 3D collagen
environment is due partially or completely to the differences in genetics, rather
than a difference in tumorigenicity. However when ME cells having a matched
genetic background (T4-2 and S1) were grown in 3D Matrigel, they had
completely different responses (Debnath and Brugge, 2005b). While the
nontumorigenic S1cells formed acini and the cells in the middle underwent
apoptosis, tumorigenic T4-2 cells continuously grew and showed disorganized
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structures. MCF10A cells express much lower cyclin E1 protein and do not
express LMW cyclin E1 isoforms compared to MDA-MB-231 cells (Fig. 2.2),
leading us to believe that the differences seen upon 3D collagen culture between
these cells are at least partially due to the tumorigenic potential of MDA-MB-231
cells. In order to compare cells with a similar genetic background, we have
begun to revert MDA-MB-231 cells to a non-invasive phenotype. MDA-MB-231
cells lack E-Cadherin expression and have been successfully reverted to form
morphologically normal structures in 3D Matrigel by combining E-Cadherin
expression with a β1-integrin/PI3K/MAPK inhibitor (Wang et al., 2002). We have
successfully overexpressed E-Cadherin in MDA-MB-231 cells (Appendix, Fig.
6.2), as the first step towards this goal.
The preliminary results from the breast cancer cell line T4-2 were
consistent with those from MDA-MB-231 cells. This cell line evolved from a line
of immortalized normal human ME cells and is tumorigenic, exhibiting highly
disordered growth in 3D Matrigel culture (Debnath and Brugge, 2005b). Growth
on collagen coated dishes is required for them to maintain their tumorigenic
phenotype. T4-2 breast cancer cells showed decreased proliferation in 3D
collagen when compared to 2D collagen, along with increased apoptotic cells,
similar to MDA-MB-231 cells, although this experiment needs to be repeated.
Western analysis showed that only LMW cyclin E1 decreased in 3D collagen, not
full length cyclin E1. The decrease of this LMW isoform in 3D collagen was also
seen in MDA-MB-231 cells (data not shown), although it was along with a
decrease of full-length cyclin E1. The ratio of each cyclin E1 LMW isoform as

84

compared to the full length protein has not been reported, except for a 43-kDa
splice variant that was reported to be expressed at 1/10 the level of full length
cyclin E1 (Sewing et al., 1994). The preferential decrease in LMW cyclin E1 may
be due to a 3D collagen environment decreasing full length isform and thus the
LMW isoforms, if they result from proteolytical processing of overexpressed full
length protein (Porter et al., 2001); or by affecting alternative splicing of the cyclin
E1 mRNA (Porter and Keyomarsi, 2000a). Considering that LMW cyclin E1
isoforms have higher affinity for cdk2 and are resistant to cdk inhibitors, as well
as strongly correlate with decreased survival in breast cancer, their reduction by
a 3D collagen environment in both T4-2 and MDA-MD-231 cells warrants further
investigation. In addition, we transfected MDA-MB-231 cells with one of the LMW
isoforms (Appendix, Fig. 6.3), providing the first step to re-rexpressing cyclin E1
to determine if proliferation reduction in 3D collagen will be rescued.
In summary, we used the nontumorigenic ME cell line MCF10A and the
malignant ME cell line HMT-3522 T4-2 to show that an ECM composed of
collagen I negatively regulates the cell cycle in part through downregulation of
cyclin E1, similar to what we have shown for MDA-MB-231 cells. Although both
cell lines showed suppressed cell proliferation in 3D collagen, differences from
MDA-MB-231 cells were also obvious, as synchronous MCF10A cells
subsequently underwent apoptosis and T4-2 cells decreased only a LMW
isoform of cyclin E1. Whether cyclin E1 contributed to apoptosis and whether the
cyclin E1 LMW isoform is differentially regulated compared to full-length cyclin
E1 in T4-2 cells embedded in 3D collagen, need further investigation.
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4.6. Figures and Figure Legends

Figure 4.1 MCF10A cells undergo G1 cell cycle arrest in 3D collagen.
Cells grown on 2DP and 3DCI to 50%-60% confluence were synchronized
in G1/S boundary by serum deprivation for 48h followed by 24h treatment with
5µg/ml aphidicolin. Cells were then stimulated with serum and harvested at the
indicated times for FACS as described in Chapter 2, section 2.3.2.
cycle analysis of synchronous MCF10A cells on 2DP, courtesy of

a.

Cell

Dr. Xun Guo

(Guo and Hartley, 2006). b. Cell cycle analysis of synchronous MCF10A cells in
3DCI. Experiment was performed once.
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Figure 4.2 Collagen culture decreased cyclin E1 mRNA in MCF10A cells.
Cyclin E1 mRNA level was determined by real-time RT-PCR. Threshold
cycles (Ct values) were normalized to GAPDH and plotted as relative mRNA
levels. Data is average of 3 experiments. Values were expressed as mean ± SD
and assessed by Student’s t test.

P
P
*p < 0.05 vs. 2D , **p < 0.01 vs. 2D
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Figure 4.3 Quantitative analysis of mitosis and apoptosis in MDA-MB-231
and T4-2 cells.

a. Quantitative analysis of mitosis and apoptosis in asynchronous MDAMB-231 cells. Immunofluorescence assay using Phospho-Histone H3 (Ser 10)
antibody was performed to monitor cell proliferation in MDA-MB-231 cells
cultured in 2DP, 2DCI and 3DCI. Upper panel: Percentage of phospho-H3+ cells
was calculated by counting at least 20 40X fields (at least 500 cells) per
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condition. Bottom panel: Percentage of apoptotic cells was calculated by
counting condensed and fragmented nuclei stained with DAPI, at least 20 40X
fields (at least 500 cells) per condition.

Data is the average from 3 experiments.

Values were expressed as mean ± SD and assessed by Student’s t test.
0.05 vs. 2DP,

*p <

∆

p < 0.05 vs. 2DCI b. Percentage of hypodiploid cells in

synchronous MDA-MB-231 cells was plotted for the indicated time points of Fig.
2.2. Data is representative of 2 experiments. c. 3D collagen decreased
proliferation

and

increased

apoptosis

in

HMT-3522

T4-2

cells.

Immunofluorescence assay monitoring Phospho-Histone H3 (Ser 10) staining
CI

was done as described above in T4-2 cells cultured in 2D

and 3DCI. Upper

panel: Percentage of phospho-H3+ cells. Bottom panel: Percentage of apoptotic
cells. Values were expressed as a mean of 2 experiments.
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Figure 4.4 3D collagen decreased the 40kDa LMW isoform of cyclin E1 in
T4-2 cells.

Western blots of cyclin E1 in T4-2 cells cultured on 2DCI and 3DCI. Data
is representative of 3 experiments. The relative quantity of cyclin E1 and was
calculated after normalization to actin, expressed as mean ± SD and assessed
by Student’s t test. **p < 0.01 vs. 2DCI.
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5.

Chapter 5: Final Conclusion/Discussion

In this project, we set out to determine if the breast cancer
microenvironment controls the cell cycle in part through direct regulation of cyclin
E1. We conclude that a 3D environment composed of collagen I, which mimics
the environment when breast cancer cells first invade through the basement
membrane into the interstitial stroma, can control the cell cycle in part through
negative regulation of cyclin E1. Support for this conclusion has been obtained in
different mammary epithelial cell lines including nontumorigenic MCF-10A cells,
and tumorigenic MDA-MB-231 and HMT-3522 T4-2 cells, although most of our
data are based on the highly invasive MDA-MB-231 adenocarcinoma cells.
Importantly, this negative regulation is specific to 3D collagen as compared to 2D
plastic and 2D collagen, providing strong evidence for the essential differences
between 2D and 3D culture systems, and emphasizing the importance of
considering the role of ECM when studying human cancers.
A model based on our data is presented in Fig. 5.1, to summarize the
possible mechanisms by which 3D collagen controls the breast cancer cell cycle
in comparison to 2D collagen. As shown in the left panel, when ME cells adhere
to 2D collagen, mitogenic growth factors and cell anchorage through β1 integrin
converge on signalling pathways that result in activating cyclin D1/cdk4/6 activity
(Bohmer et al., 1996). In the nucleus, cyclin D1 inhibits Rb by phosphorylation
and this releases transcription factor E2F, promoting cyclin E1 transcription.
Collagen adhesion also induces the transcription factor c-Myc through activation
of the Src and MAPK signalling pathways (Benaud and Dickson, 2001b). This
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can be independent of cyclin D1 and directly upregulates cyclin E1 expression
(Benaud and Dickson, 2001a). Increased cyclin E1 promotes the G1/S transition.
In contrast, when ME cells are embedded in 3D collagen I (Fig. 5.1, right panel),
cell proliferation is suppressed. Contact with 3D collagen induces a dramatic
increase in β1 integrin, followed by a decrease in c-Myc, cyclin D1 relocalization
to the cytoplasm, and dephosphorylation of Rb. Thus E2F remains inactive and
cyclin E1 transcription decreases. CIRP decreases in 3D collagen as well as
relocalizes to the cytoplasm, without changing cyclin E1 mRNA stability.
In this model, several unresolved questions are worth further investigation.
First, although β1 integrin-mediated signalling seems to be involved in both 2D
and 3D collagen regulation of cell cycle, the detailed signalling pathways in the
3D culture system have not been identified. β1 integrin has been shown to
positively regulate c-Myc expression through activation of Src and MAPK in 2D
collagen. However, increased expression of β1 integrin is associated with a
decrease of c-Myc in 3D collagen. Whether Src or MAPK activation is decreased
in 3D collagen and is involved in c-Myc regulation, or whether other signalling
pathways are involved, needs future study.
Second, the mechanism of Rb downregulation and its phosphorylation in
3D collagen needs further study. Although decreased cyclin E1 can result in
hypophosphorylation of Rb and further decrease cyclin E1 itself (Donnellan and
Chetty, 1999), cyclin D1 as another direct Rb inhibitor, does not change its
expression. Since cyclin D1 phosphorylates Rb in the nucleus, its relocalization
to the cytoplasm could also contribute to Rb hypophosphorylation. Arguing

92

against this, its relocalization is not affected by integrin inhibition while cyclin E1
expression and Rb phosphorylation are restored. This indicates that if cyclin D1
regulates Rb phosphorylation in 3D collagen, it is independent of integrinmediated pathways. Whether there are other signalling pathways downstream of
β1 integrin that directly mediate Rb phosphorylation independent of effects on
cyclin D1 and cyclin E1 in 3D collagen needs further study. We are not aware of
any studies describing the direct regulation of Rb downstream of integrin
bypassing cyclin-cdk regulation.
Third, MDA-MB-231 cells lack αB-crystallin, a component of the E3 ligase
that mediates cyclin D1 degradation due to a chromosomal deletion (Lin et al.,
2008). Knockdown of αB-crystallin inhibits cyclin D1 proteolysis and leads to its
nuclear accumulation and cell transformation (Barbash et al., 2008), explaining
the predominantly nuclear cyclin D1 in MDA-MB-231 cells cultured in 2D. The
observation that in 3D collagen, cyclin D1 relocalizes from the nucleus to the
cytoplasm and remains there after integrin inhibition is surprising. GSK3β
phosphorylates cyclin D1 and triggers its nuclear export. Therefore, cyclin D1
may be phosphorylated by GSK3β in response to a 3D collagen environment,
resulting in cyclin D1 nuclear export. GSK3β also phosphorylates cyclin E1 and
promotes cyclin E1 degradation. Whether GSK3β plays a role in regulating cyclin
E1 degradation and cyclin D1 localization in 3D collagen should be assessed in
future experiments (Cohen and Goedert, 2004).
Lastly, as a relatively novel RBP, the regulation of CIRP in 3D collagen is
also worth further study. CIRP is overexpressed in about 30% of primary breast
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cancers (Artero-Castro et al., 2009). We have shown that CIRP stabilizes cyclin
E1 mRNA in breast cancer cells and localizes both in the nucleus and in discrete
cytoplasmic foci identified as stress granules (Guo et al., 2009). In a 3D collagen
environment, CIRP decreases and relocalizes to the cytoplasm without changing
cyclin E1 mRNA half-life. CIRP has been reported to act as a translational
repressor (De Leeuw et al., 2007). Cytoplasmic CIRP contributing to cyclin E1
downregulation via repressing its translation remains a possibility.
The ability to directly regulate cyclin E1 in the absence of nuclear cyclin
D1 may be an adaptation of MDA-MB-231 and other cancer cells for survival and
growth in a primarily collagen environment after invasion and during metastasis.
This adaptation may result from upregulation of integrin and integrin mediated
signalling pathways that promote cell survival. β integrins deliver prosurvival
messages by activating downstream signalling pathways such as FAK/JNK (cJun N-terminal kinase) or NFκB (nuclear factor kappa-light-chain-enhancer of
activated B cells) in ME cells (Hehlgans et al., 2007). Whether these signalling
pathways are activated in 3D collagen needs future investigation.
MMPs are highly expressed in breast cancer and invasive breast cancer
growth is preceded by an increase in MMP activity (Duffy et al., 2000). Few
studies have addressed the mechanism by which MMPs regulate cell
proliferation. This may be due to the fact that MMPs usually function
extracellularly. Although MMPs have been reported to function within nuclei and
promote apoptosis via their catalytic activities (Si-Tayeb et al., 2006; Yang et al.,
2009) and cyclin E1 decreases in 3D collagen and also might be involved in
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apoptosis, we have not found MMPs in the nucleus of 3D collagen culture by
immunofluorescence assays (courtesy of Dr. Paul McGuire, UNM-HSC, data not
shown), excluding the possibility that MMPs cleave cyclin E1 in the nucleus. We
have shown that inhibition of MMPs might rescue cyclin E1 (p=0.05) without
changing cyclin D1 relocalization. In order to determine the mechanisms
responsible for MMP regulation of cyclin E1, other factors involved in cyclin E1
regulation, such as c-Myc, Rb, CIRP or signalling pathways, can be examined
upon MMP inhibition. Our results suggest that MDA-MB-231 cells possibly
activate MMP-2 and MMP-9 through β1 integrin-mediated interaction with
collagen I (as discussed in Chapter 3, section 3.4). The increase seen in β1
integrin and MMPs coupled to decreased cell proliferation in 3D collagen might
indicate a cell behavior transition from growth to invasion. Determining whether
MDA-MB-231 cells become more invasive in 3D collagen and whether β1 integrin
is involved in regulating cell invasion would provide evidence for this. Further
elucidation of the mechanisms by which a 3D collagen ECM controls ME cell
proliferation, invasion and survival via a balance adjustment between
extracellular proteases, cell surface receptors and cell cycle regulators is
needed.
Monotypic 3D culture models are only one of several models that have
been successfully utilized to study microenvironmental contributions to the
normal and malignant mammary gland. Heterotypic 3D models in which different
cell types are co-cultured, better mimic the in vivo environment and are better
suited to investigate more complicated cellular interactions (Gudjonsson et al.,
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2002; Krause et al., 2008). The “humanized” mammary gland model has also
allowed the study of mammary gland development and carcinogenesis in vivo
(Kuperwasser et al., 2004). This model was generated by clearing ME cells from
the mammary gland of immunocompromised mice and sequentially injecting
irradiated human fibroblasts and then normal human mammary tissue mixed with
human primary fibroblasts and collagen/Matrigel into the cleared mammary fat
pad. Human ME cells survived and integrated within the mouse mammary
stroma and development of human breast ducts were observed. However, these
models are limited in that the tumor microenvironment differs from normal tissue
stroma; mutations that cause embryonic lethality or impede mammary gland
development are difficult if not impossible to study in these models. The
development of innovative 3D culture systems will be invaluable in modeling
breast cancer progression and identifying new strategies for its therapy.
Although using a relatively simple monotypic 3D culture system, our study
directly answered an important question about how the major component of the
early stage breast cancer microenvironment, collagen I, exerts its control on
cancer cell proliferation. Our studies focused on regulation of cyclin E1, a G1/S
regulator often perturbed in breast cancer and involved in its etiology. Our results
show a network of regulation involving other cell cycle regulators, transcriptional
and post-transcriptional regulatory factors as well as cell surface receptors and
extracellular proteases. A number of promising future directions and possible
signalling pathways merit continued study and exploration.
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Figure and Figure Legend

Figure 5.1 Model.
A model to summarize the possible mechanisms identified in our project
by which 3D collagen controls the cell cycle in part through cyclin E1, compared
with regulation by 2D collagen. Crossed lines on top indicate ECM composed of
collagen I. Outer circle indicates cell surface and inner circle indicates nucleus.
Mechanisms are discussed in the text. Left panel: β1 integrin mediated signalling
pathways when ME cells adhere to 2D collagen. Right panel: β1 integrin
mediated signalling pathways when ME cells are embedded in 3D collagen. Solid
line arrows: positive regulation shown previously or in the current study. Solid
lines with perpendicular bar: negative regulation shown previously or in the
current study. Dashed line: regulation proposed based on published data.
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6.

Appendix-Pilot Studies

Figure 6.1 MT1-MMP cloning.
MT1-MMP was cloned from MCF10A cDNA. Agarose gel showing PCR
cloning of the full length MT1-MMP coding sequence (~1.7kb). PCR was
performed under 4 different conditions: with Taq polymerase (Taq), Taq
polymerase plus Betaine (Taq+Betaine), HotStart Taq polymerase (HotStar), or
HotStar Taq polymerase plus Betaine (HotStar+Betaine). M: DNA HyperLadder I
(Bioline, Taunton, MA). Total RNA from MCF10A cells was extracted using Trizol
reagent (Invitrogen, Carlsbad, CA) and reverse transcription was performed
using Oligo (dT)12-18 as described in Chapter 2, section 2.3.4.

MT1-MMP was

cloned from the resulting cDNA with the following primer pairs by PCR: forward:
5’-GAA AGATCT ACC ATG TCT CCC GCC CC-3’ and reverse: 5’-CCG
GAATTC TCA GAC CTT GTC CAG-3’. The reaction was performed using
HotStar Taq PCR kit (QIAGEN, Valencia, CA) with 1M Betaine (Sigma, St. Louis,
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MO) to improve the yield by reducing the formation of secondary structure in GCrich regions.

PCR was performed as: 95°C 15min followed by 35 cycles of

94°C 1min, 60°C 30sec, 72°C 2.5min, and 72°C 10min.
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Figure 6.2 E-Cadherin was overexpressed in MDA-MB-231 cells.
Upper panel: E-Cadherin was visualized with Alexa Fluor 488 conjugated
secondary antibody (green). Nuclei were stained with DAPI (blue). Transfection
efficiency was about 10%. Magnification 63X. Bottom Panel: E-Cadherin
expression was monitored by western blotting of cell lysates from untransfected
MDA-MB-231 cells or cells stably transfected with empty vector (pEGFP-C1) or
untagged E-Cadherin (pC1-ECAD). Actin was used as a loading control.

A

pBluescript II phagemid bearing the coding sequence of E-Cadherin was
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provided courtesy of Dr. Helen Hathaway (UNM-HSC). E-Cadherin was
subcloned into pEGFP-C1 with or without the EGFP tag. Primers used for
cloning E-Cadherin downstream of EGFP were: forward 5’5'CCG CTCGAG CGG
ATG GGC CCT TGG AGC CGC AGC 3'; reverse 5'TCC CCGCGG GGA CTA
GTC GTC CTC GCC GCC TCC GTA 3'. Primers used for replacing EGFP
sequence with the E-Cadherin coding sequence were: forward 5'GTT GCTAGC
ATG GGC CCT TGG AGC CGC AGC 3'; reverse 5'TTA CTCGAG TCC CCT
AGT CGT CCT CGC CGC CTC CG 3'. Both constructs were sequenced to
confirm that E-Cadherin was correctly cloned. Lipofectamine2000 (Invitrogen,
Carlsbad, CA) was used to transfect pEGFP-E-Cadherin, or pC1-E-Cadherin (no
EGFP) or empty vector into MDA-MB-231 cells. Transfection efficiency was
monitored by visualizing EGFP fluorescence or western blotting for E-Cadherin in
cell lysates. Immunofluorescence assays using untagged E-Cadherin antibody
(BD Biosciences, San Jose, California) and nonspecific mouse IgG (Santa Cruz
Biotechnology, Santa Cruz, CA) also performed to visualize E-Cadherin.
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6.1.1.

Figure 6.3 40kDa LMW cyclin E1 was transfected in MDA-MB-231 cells.
Expression of a 40kDa LMW isoform of cyclin E1 in MDA-MB-231 cells.
Expression was monitored by western blotting for cyclin E1 using cell lysates
from untransfected (control), empty vector transfected (vector) and 40kDa
isoform (E1 LMW) stably transfected MDA-MB-231 cells. Actin was used as a
loading control. pTracer-CMV2-E1Trunk2 vector containing a LMW

cyclin E1

isoform of 40kDa was provided by Dr. Xun Guo (UNM-HSC). Fugene 6 was used
to transfect LMW cyclin E1 vector or empty vector into MDA-MB-231 cells
(Roche, Basel, CN) according to the manufacturer’s directions. Western Blotting
for Cyclin E1 verified expression of the 40kDa cyclin E1 isoform.
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